thaigirl的个人主页 - 老虎社区

thaigirl

thaigirl

暂无个人介绍

IP属地：未知

49关注

7粉丝

0主题

0勋章

2021-12-23

ah

抱歉，原内容已删除

2021-12-23

ah

抱歉，原内容已删除

2021-12-22

ah

抱歉，原内容已删除

2021-12-15

ah

Singapore Home Sales Reach Four-Month High as Economy Reopens

2021-12-15

ah

抱歉，原内容已删除

2021-12-15

ah

Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation

2021-12-02

ah

Razer will be privatized at a price of HK $2.82 per share

2021-11-27

ah

Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'

2021-11-23

ah

Xiaomi revenue misses estimates as competition intensifies

2021-11-18

ah

Starbucks, Amazon team up to open cashier-less store, cafe in NYC

2021-11-18

ah

抱歉，原内容已删除

2021-11-13

ah

Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?

2021-11-13

ah

Buy the Elon Musk Dip in Tesla Stock?

2021-11-13

ah

抱歉，原内容已删除

2021-11-10

suspend

Keppel raises SPH bid to S$2.351 a share, cash component up by 20 cents; says price is final

2021-11-08

ah

抱歉，原内容已删除

2021-10-22

ah

US Manufacturing Survey Slumps To 7-Month-Low, Services Jump In October

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4087725712090890,"uuid":"4087725712090890","gmtCreate":1624622918396,"gmtModify":1634693482303,"name":"thaigirl","pinyin":"thaigirl","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":49,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.50%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.11","exceedPercentage":"80.51%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":691727515,"gmtCreate":1640248798723,"gmtModify":1640248798854,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691727515","repostId":"1138529637","repostType":4,"isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691727610,"gmtCreate":1640248731342,"gmtModify":1640248731527,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691727610","repostId":"2193423197","repostType":4,"isVote":1,"tweetType":1,"viewCount":657,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691169180,"gmtCreate":1640150438778,"gmtModify":1640150438917,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691169180","repostId":"1157657338","repostType":4,"isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607594306,"gmtCreate":1639558189048,"gmtModify":1639558189137,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607594306","repostId":"1196328402","repostType":4,"repost":{"id":"1196328402","pubTimestamp":1639551661,"share":"https://www.laohu8.com/m/news/1196328402?lang=&edition=full","pubTime":"2021-12-15 15:01","market":"sg","language":"en","title":"Singapore Home Sales Reach Four-Month High as Economy Reopens","url":"https://stock-news.laohu8.com/highlight/detail?id=1196328402","media":"Bloomberg","summary":"Purchases of new private units surged to 1,547 in November\nCity is gradually easing virus curbs desp","content":"<ul>\n <li>Purchases of new private units surged to 1,547 in November</li>\n <li>City is gradually easing virus curbs despite omicron risks</li>\n</ul>\n<p>Singapore home sales surged to a four-month high after the city-state gradually eased social restrictions in a bid to live with the virus.</p>\n<p>Purchases of new private apartments climbed to 1,547 units in November, Urban Redevelopment Authority figures showed Wednesday. That’shigherthan the 911 units sold in the previous month and the most since July.</p>\n<p>The rebound came after Singapore began to&nbsp;relax&nbsp;its strict virus curbs in early November, including on social gatherings, which allowed more people to view new homes. Demand has been resilient even during the pandemic restrictions as some buyers cashed out of their old apartments and others sought to upgrade from public flats.</p>\n<p>The market could potentially rise further next year as foreign buyers look to invest in residential properties after Singapore opened up more vaccinated travel lanes.</p>\n<p>Though the omicron variant poses risks, Singapore’s authorities have yet to&nbsp;dial back&nbsp;loosening measures. The city-state’s daily Covid-19 tally has been below 800 cases in the past week, and its infection rate has dipped.</p>\n<p>Last month’s sales could be attributed to two major launches, including the 696-unit CanningHill Piers located on the outskirts of the central business district with a view of the Singapore River, said Christine Sun, senior vice president of research and analytics at OrangeTee &amp; Tie.</p>\n<p>“More units were also launched last month,” she said. “Developers were keen to ride the wave of positive sales momentum and close more deals before the year ends.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Home Sales Reach Four-Month High as Economy Reopens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Home Sales Reach Four-Month High as Economy Reopens\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 15:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-15/singapore-home-sales-reach-four-month-high-as-economy-reopens><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Purchases of new private units surged to 1,547 in November\nCity is gradually easing virus curbs despite omicron risks\n\nSingapore home sales surged to a four-month high after the city-state gradually ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-15/singapore-home-sales-reach-four-month-high-as-economy-reopens\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-15/singapore-home-sales-reach-four-month-high-as-economy-reopens","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196328402","content_text":"Purchases of new private units surged to 1,547 in November\nCity is gradually easing virus curbs despite omicron risks\n\nSingapore home sales surged to a four-month high after the city-state gradually eased social restrictions in a bid to live with the virus.\nPurchases of new private apartments climbed to 1,547 units in November, Urban Redevelopment Authority figures showed Wednesday. That’shigherthan the 911 units sold in the previous month and the most since July.\nThe rebound came after Singapore began to relax its strict virus curbs in early November, including on social gatherings, which allowed more people to view new homes. Demand has been resilient even during the pandemic restrictions as some buyers cashed out of their old apartments and others sought to upgrade from public flats.\nThe market could potentially rise further next year as foreign buyers look to invest in residential properties after Singapore opened up more vaccinated travel lanes.\nThough the omicron variant poses risks, Singapore’s authorities have yet to dial back loosening measures. The city-state’s daily Covid-19 tally has been below 800 cases in the past week, and its infection rate has dipped.\nLast month’s sales could be attributed to two major launches, including the 696-unit CanningHill Piers located on the outskirts of the central business district with a view of the Singapore River, said Christine Sun, senior vice president of research and analytics at OrangeTee & Tie.\n“More units were also launched last month,” she said. “Developers were keen to ride the wave of positive sales momentum and close more deals before the year ends.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607595322,"gmtCreate":1639558142474,"gmtModify":1639558142604,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607595322","repostId":"1160618167","repostType":4,"isVote":1,"tweetType":1,"viewCount":434,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607592611,"gmtCreate":1639558048783,"gmtModify":1639558048926,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607592611","repostId":"1107549050","repostType":4,"repost":{"id":"1107549050","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639552499,"share":"https://www.laohu8.com/m/news/1107549050?lang=&edition=full","pubTime":"2021-12-15 15:14","market":"us","language":"en","title":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=1107549050","media":"Tiger Newspress","summary":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and c","content":"<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p>\n<ul>\n <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>\n <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>\n <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li>\n</ul>\n<p>Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p>\n<p>The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p>\n<p>Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p>\n<p><i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p>\n<p>Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p>\n<p>In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p>\n<p><b>About the booster trial (VAT0002)</b></p>\n<p>The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p>\n<p>Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p>\n<p>The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p>\n<p><b>About the Phase 3 efficacy trial (VAT0008)</b></p>\n<p>The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p>\n<p>These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p>\n<p><b>About the Sanofi and GSK collaboration</b></p>\n<p>In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p>\n<p><b>About GSK</b></p>\n<p>GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p>\n<p><b>About Sanofi</b></p>\n<p>Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p>\n<p>With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-15 15:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p>\n<ul>\n <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>\n <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>\n <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li>\n</ul>\n<p>Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p>\n<p>The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p>\n<p>Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p>\n<p><i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p>\n<p>Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p>\n<p>In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p>\n<p><b>About the booster trial (VAT0002)</b></p>\n<p>The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p>\n<p>Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p>\n<p>The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p>\n<p><b>About the Phase 3 efficacy trial (VAT0008)</b></p>\n<p>The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p>\n<p>These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p>\n<p><b>About the Sanofi and GSK collaboration</b></p>\n<p>In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p>\n<p><b>About GSK</b></p>\n<p>GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p>\n<p><b>About Sanofi</b></p>\n<p>Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p>\n<p>With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNY":"赛诺菲安万特","GSK":"葛兰素史克"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107549050","content_text":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation\n\nPositive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile\nPhase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022\nCompanies intend to file booster data with regulatory authorities following the Phase 3 results\n\nSanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson & Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.\nThe ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.\nRegulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.\n“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”\nRoger Connor, President of GSK Vaccines, added: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"\nIn parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson & Johnson vaccines.\nAbout the booster trial (VAT0002)\nThe VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.\nParticipants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson & Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.\nThe trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.\nAbout the Phase 3 efficacy trial (VAT0008)\nThe primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants >18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.\nThese efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.\nAbout the Sanofi and GSK collaboration\nIn the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.\nAbout GSK\nGSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.\nAbout Sanofi\nSanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.\nWith more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.","news_type":1},"isVote":1,"tweetType":1,"viewCount":517,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603225178,"gmtCreate":1638415865790,"gmtModify":1638416122805,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603225178","repostId":"1197247033","repostType":2,"repost":{"id":"1197247033","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638406745,"share":"https://www.laohu8.com/m/news/1197247033?lang=&edition=full","pubTime":"2021-12-02 08:59","market":"hk","language":"en","title":"Razer will be privatized at a price of HK $2.82 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=1197247033","media":"Tiger Newspress","summary":"A consortium led by the founders of gaming equipment maker Razer Inc. have made an offer of up to 10","content":"<p>A consortium led by the founders of gaming equipment maker Razer Inc. have made an offer of up to 10.79 billion Hong Kong dollars (US$1.38 billion) to take the Hong Kong-listed company private.</p>\n<p>Private-equity firm CVC Capital Partners is part of the consortium, Razer said Thursday in a filing to the Hong Kong bourse.</p>\n<p>The consortium is offering HK$2.82 a share to buy all shares it doesn't currently hold, representing a 5.6% premium to the stock's last closing price. The offer is final, Razer said.</p>\n<p>Razer, which sells gear for gamers such as keyboards and headphones and has bases in California and Singapore, was founded in 2005 and went public in 2017. Shares are up 12% this year, but remain well below their initial public offering price.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Razer will be privatized at a price of HK $2.82 per share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRazer will be privatized at a price of HK $2.82 per share\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-02 08:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>A consortium led by the founders of gaming equipment maker Razer Inc. have made an offer of up to 10.79 billion Hong Kong dollars (US$1.38 billion) to take the Hong Kong-listed company private.</p>\n<p>Private-equity firm CVC Capital Partners is part of the consortium, Razer said Thursday in a filing to the Hong Kong bourse.</p>\n<p>The consortium is offering HK$2.82 a share to buy all shares it doesn't currently hold, representing a 5.6% premium to the stock's last closing price. The offer is final, Razer said.</p>\n<p>Razer, which sells gear for gamers such as keyboards and headphones and has bases in California and Singapore, was founded in 2005 and went public in 2017. Shares are up 12% this year, but remain well below their initial public offering price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01337":"雷蛇"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197247033","content_text":"A consortium led by the founders of gaming equipment maker Razer Inc. have made an offer of up to 10.79 billion Hong Kong dollars (US$1.38 billion) to take the Hong Kong-listed company private.\nPrivate-equity firm CVC Capital Partners is part of the consortium, Razer said Thursday in a filing to the Hong Kong bourse.\nThe consortium is offering HK$2.82 a share to buy all shares it doesn't currently hold, representing a 5.6% premium to the stock's last closing price. The offer is final, Razer said.\nRazer, which sells gear for gamers such as keyboards and headphones and has bases in California and Singapore, was founded in 2005 and went public in 2017. Shares are up 12% this year, but remain well below their initial public offering price.","news_type":1},"isVote":1,"tweetType":1,"viewCount":496,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600027311,"gmtCreate":1638015721292,"gmtModify":1638015722167,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600027311","repostId":"2186344334","repostType":4,"repost":{"id":"2186344334","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1637967996,"share":"https://www.laohu8.com/m/news/2186344334?lang=&edition=full","pubTime":"2021-11-27 07:06","market":"hk","language":"en","title":"Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'","url":"https://stock-news.laohu8.com/highlight/detail?id=2186344334","media":"Dow Jones","summary":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks su","content":"<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&amp;P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-27 07:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&amp;P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4528":"SaaS概念","BK4023":"应用软件","BK4190":"消闲用品","PTON":"Peloton Interactive, Inc.","BK4525":"远程办公概念","BK4532":"文艺复兴科技持仓","BK4566":"资本集团","BK4554":"元宇宙及AR概念","ZM":"Zoom","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4505":"高瓴资本持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186344334","content_text":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.\nU.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.\nHow are stock-index futures trading?\nOn Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.\nWhat's driving the market?\nIt was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.\nLate in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.\nFear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.\nParticularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.\nThe discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.\n\"The pandemic and COVID variants remain one of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.\nThe omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.\n\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"\n\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.\nTrading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.\nAfter new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.\nThe U.K. government is banning flights from South Africa along with five other African nations, effective Friday.\n\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.\n\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.\n\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":638,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875274018,"gmtCreate":1637663847626,"gmtModify":1637663847626,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875274018","repostId":"1100407650","repostType":4,"repost":{"id":"1100407650","pubTimestamp":1637663293,"share":"https://www.laohu8.com/m/news/1100407650?lang=&edition=full","pubTime":"2021-11-23 18:28","market":"hk","language":"en","title":"Xiaomi revenue misses estimates as competition intensifies","url":"https://stock-news.laohu8.com/highlight/detail?id=1100407650","media":"Reuters","summary":"SHANGHAI, Nov 23 (Reuters) - Chinese smartphone maker Xiaomi Corp(1810.HK)on Tuesday reported a smal","content":"<p>SHANGHAI, Nov 23 (Reuters) - Chinese smartphone maker Xiaomi Corp(1810.HK)on Tuesday reported a smaller than expected 8.2% rise in third-quarter revenue, hurt by intensifying competition from domestic rivals Oppo and Vivo.</p>\n<p>Sales rose to 78.06 billion yuan ($12.22 billion) in the three months to Sept. 30. Analysts had expected 79.20 billion yuan, Refinitiv data shows.</p>\n<p>Profit slumped 84% to 788.6 million yuan.</p>\n<p>On an adjusted basis, Xiaomi earned 5.18 billion yuan, largely in line with the average analyst expectations for 5.09 billion yuan.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xiaomi revenue misses estimates as competition intensifies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXiaomi revenue misses estimates as competition intensifies\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-23 18:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/media-telecom/xiaomi-q3-revenue-up-82-year-on-year-7806-bln-yuan-misses-estimtes-2021-11-23/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SHANGHAI, Nov 23 (Reuters) - Chinese smartphone maker Xiaomi Corp(1810.HK)on Tuesday reported a smaller than expected 8.2% rise in third-quarter revenue, hurt by intensifying competition from domestic...</p>\n\n<a href=\"https://www.reuters.com/business/media-telecom/xiaomi-q3-revenue-up-82-year-on-year-7806-bln-yuan-misses-estimtes-2021-11-23/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01810":"小米集团-W"},"source_url":"https://www.reuters.com/business/media-telecom/xiaomi-q3-revenue-up-82-year-on-year-7806-bln-yuan-misses-estimtes-2021-11-23/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100407650","content_text":"SHANGHAI, Nov 23 (Reuters) - Chinese smartphone maker Xiaomi Corp(1810.HK)on Tuesday reported a smaller than expected 8.2% rise in third-quarter revenue, hurt by intensifying competition from domestic rivals Oppo and Vivo.\nSales rose to 78.06 billion yuan ($12.22 billion) in the three months to Sept. 30. Analysts had expected 79.20 billion yuan, Refinitiv data shows.\nProfit slumped 84% to 788.6 million yuan.\nOn an adjusted basis, Xiaomi earned 5.18 billion yuan, largely in line with the average analyst expectations for 5.09 billion yuan.","news_type":1},"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878782084,"gmtCreate":1637233583025,"gmtModify":1637233583025,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878782084","repostId":"1171955198","repostType":4,"repost":{"id":"1171955198","pubTimestamp":1637233373,"share":"https://www.laohu8.com/m/news/1171955198?lang=&edition=full","pubTime":"2021-11-18 19:02","market":"us","language":"en","title":"Starbucks, Amazon team up to open cashier-less store, cafe in NYC","url":"https://stock-news.laohu8.com/highlight/detail?id=1171955198","media":"Yahoo","summary":"Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in ","content":"<p>Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.</p>\n<p>The new Starbucks Pickup, located at 59th Street between Park &amp; Lexington Avenue, is set to open to the public on Thursday, November 18th. The retail experience uses the order ahead feature on the Starbucks app and Amazon Go’s Just Walk Out technology to create a touch-less experience, the companies announced on Thursday.</p>\n<p>The team-up is part of the ongoing COVID-19 era trend to leverage technology in favor of human contact to expedite requests, as well as reduce the chances of transmission.</p>\n<p>The two powerhouses are teaming up to create \"a common vision to provide innovative in-store experiences that are centered on the customer,” Dilip Kumar, Amazon's VP of physical retail and technology, said in a statement.</p>\n<p>Dubbed Starbucks Pickup with Amazon Go, the system gives customers the ability to choose their experience, \"whether it is utilizing the Starbucks and Amazon apps to purchase food and beverages on the go, or deciding to stay in the lounge for the traditional third place experience Starbucks is known for,” Starbucks executive Katie Young said.</p>\n<p>In order to enter the Amazon GO market and the store's lounge area, they must scan the \"In-Store Code\" in the Amazon Shopping app, Amazon One or a credit card. Once consumers enter the location, they can shop the market like any other Amazon Go location, grab their Starbucks mobile order and leave — or choose to stay a while.</p>\n<p>When guests take any item off the shelf, it will immediately be added to their virtual cart, and if customers put back an item, it will come out of the cart. Once the customer leaves the Amazon Go market portion of the store, their card will be charged and the receipt is expected to follow within a few hours, if not faster, according to the release.</p>\n<p>Items that will be available for pickup include classic Starbucks fare like Sous Vide Egg Bites, breakfast sandwiches and protein boxes, in addition to items that are found at other Amazon Go locations. Those include its Kitchen Turkey and Cheddar Sandwich, and the Buffalo-Style Wrap.</p>\n<p>In addition to that, the shelves will be stocked with well-known local favorites with items from Genji Sushi, York Street, Magnolia Bakery, Ess-a-bagel, among others.</p>\n<p>As Starbucks dives headfirst into digital and its&nbsp;loyalty program use soars, the companies plan to open at least three Starbucks Pickup with Amazon Go stores in total within the coming year, with the second location set to open in The New York Times Building located at 40th Street &amp; 8th Avenue.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starbucks, Amazon team up to open cashier-less store, cafe in NYC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarbucks, Amazon team up to open cashier-less store, cafe in NYC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html><strong>Yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.\nThe new Starbucks Pickup, located at 59th Street between ...</p>\n\n<a href=\"https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克","AMZN":"亚马逊"},"source_url":"https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171955198","content_text":"Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.\nThe new Starbucks Pickup, located at 59th Street between Park & Lexington Avenue, is set to open to the public on Thursday, November 18th. The retail experience uses the order ahead feature on the Starbucks app and Amazon Go’s Just Walk Out technology to create a touch-less experience, the companies announced on Thursday.\nThe team-up is part of the ongoing COVID-19 era trend to leverage technology in favor of human contact to expedite requests, as well as reduce the chances of transmission.\nThe two powerhouses are teaming up to create \"a common vision to provide innovative in-store experiences that are centered on the customer,” Dilip Kumar, Amazon's VP of physical retail and technology, said in a statement.\nDubbed Starbucks Pickup with Amazon Go, the system gives customers the ability to choose their experience, \"whether it is utilizing the Starbucks and Amazon apps to purchase food and beverages on the go, or deciding to stay in the lounge for the traditional third place experience Starbucks is known for,” Starbucks executive Katie Young said.\nIn order to enter the Amazon GO market and the store's lounge area, they must scan the \"In-Store Code\" in the Amazon Shopping app, Amazon One or a credit card. Once consumers enter the location, they can shop the market like any other Amazon Go location, grab their Starbucks mobile order and leave — or choose to stay a while.\nWhen guests take any item off the shelf, it will immediately be added to their virtual cart, and if customers put back an item, it will come out of the cart. Once the customer leaves the Amazon Go market portion of the store, their card will be charged and the receipt is expected to follow within a few hours, if not faster, according to the release.\nItems that will be available for pickup include classic Starbucks fare like Sous Vide Egg Bites, breakfast sandwiches and protein boxes, in addition to items that are found at other Amazon Go locations. Those include its Kitchen Turkey and Cheddar Sandwich, and the Buffalo-Style Wrap.\nIn addition to that, the shelves will be stocked with well-known local favorites with items from Genji Sushi, York Street, Magnolia Bakery, Ess-a-bagel, among others.\nAs Starbucks dives headfirst into digital and its loyalty program use soars, the companies plan to open at least three Starbucks Pickup with Amazon Go stores in total within the coming year, with the second location set to open in The New York Times Building located at 40th Street & 8th Avenue.","news_type":1},"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878786608,"gmtCreate":1637233487522,"gmtModify":1637233487522,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878786608","repostId":"1184486139","repostType":4,"isVote":1,"tweetType":1,"viewCount":392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879448323,"gmtCreate":1636767722663,"gmtModify":1636767722708,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879448323","repostId":"1116750872","repostType":4,"repost":{"id":"1116750872","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1636761765,"share":"https://www.laohu8.com/m/news/1116750872?lang=&edition=full","pubTime":"2021-11-13 08:02","market":"us","language":"en","title":"Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?","url":"https://stock-news.laohu8.com/highlight/detail?id=1116750872","media":"Benzinga","summary":"Meta Platforms Inc is having a strong close thus far to end the week, up almost 3.5% and only $7 off","content":"<p><b>Meta Platforms Inc</b>&nbsp;is having a strong close thus far to end the week, up almost 3.5% and only $7 off the weekly highs.</p>\n<p><b>What Happened:</b>&nbsp;While the volume of shares traded is solid at 17 million vs. the 10 day average of 21 million, options traders are quite active on the day, trading more than&nbsp;672,970 options with 476,002&nbsp;being calls and 196,968&nbsp;being puts. This comes out to about 7 out of every 10 options being calls (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/c08237f8d7c163047e56072f027073d5\" tg-width=\"1001\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p>\n<p><b>What It Matters:</b>Prior to this Friday, there were 1,519,000 calls and 1,207,750 puts for a total of 2,726,000&nbsp;options. Hence this Friday's options activity and flows of 672,970 comprise 25% of the total option flows out there.</p>\n<p>Any time a stock trades 25% of its total options in one day, it means options traders are particularly active in the stock.</p>\n<p>Of note, only 11% of the options were set to expire this Friday (~300,000 options) so today's 672,970&nbsp;options suggest a lot more forward-looking flows.</p>\n<p><b>What's Next:</b>Looking at the option flows expiring next week on Nov. 19, you can see on the call side the majority of volume and open interest is between the $330 and $360 strikes. And on the put side, there is a consistent but small volume between the $340 and $300 strikes (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/e74f74fdf39ce74de7e0d6a88eb349c8\" tg-width=\"1743\" tg-height=\"650\" width=\"100%\" height=\"auto\"></p>\n<p>This suggests bullish traders are targeting&nbsp;between $330 and $360, but don't have&nbsp;much appetite above that. Meanwhile, bearish options traders don't see much downside below $300.</p>\n<p>It should be noted the steady volume of puts from $340 to $300 appears to be a mix of bullish traders selling cash-secured puts down to the $322.5 strike, but likely long stock traders seeking protection below that as the premium is very low.</p>\n<p>Hence bullish traders will want to see the $360 strike cleared by next week to lift their expectations higher while bears will want to see a weekly close below $300 to open up the downside.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-13 08:02</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Meta Platforms Inc</b>&nbsp;is having a strong close thus far to end the week, up almost 3.5% and only $7 off the weekly highs.</p>\n<p><b>What Happened:</b>&nbsp;While the volume of shares traded is solid at 17 million vs. the 10 day average of 21 million, options traders are quite active on the day, trading more than&nbsp;672,970 options with 476,002&nbsp;being calls and 196,968&nbsp;being puts. This comes out to about 7 out of every 10 options being calls (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/c08237f8d7c163047e56072f027073d5\" tg-width=\"1001\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p>\n<p><b>What It Matters:</b>Prior to this Friday, there were 1,519,000 calls and 1,207,750 puts for a total of 2,726,000&nbsp;options. Hence this Friday's options activity and flows of 672,970 comprise 25% of the total option flows out there.</p>\n<p>Any time a stock trades 25% of its total options in one day, it means options traders are particularly active in the stock.</p>\n<p>Of note, only 11% of the options were set to expire this Friday (~300,000 options) so today's 672,970&nbsp;options suggest a lot more forward-looking flows.</p>\n<p><b>What's Next:</b>Looking at the option flows expiring next week on Nov. 19, you can see on the call side the majority of volume and open interest is between the $330 and $360 strikes. And on the put side, there is a consistent but small volume between the $340 and $300 strikes (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/e74f74fdf39ce74de7e0d6a88eb349c8\" tg-width=\"1743\" tg-height=\"650\" width=\"100%\" height=\"auto\"></p>\n<p>This suggests bullish traders are targeting&nbsp;between $330 and $360, but don't have&nbsp;much appetite above that. Meanwhile, bearish options traders don't see much downside below $300.</p>\n<p>It should be noted the steady volume of puts from $340 to $300 appears to be a mix of bullish traders selling cash-secured puts down to the $322.5 strike, but likely long stock traders seeking protection below that as the premium is very low.</p>\n<p>Hence bullish traders will want to see the $360 strike cleared by next week to lift their expectations higher while bears will want to see a weekly close below $300 to open up the downside.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116750872","content_text":"Meta Platforms Inc is having a strong close thus far to end the week, up almost 3.5% and only $7 off the weekly highs.\nWhat Happened: While the volume of shares traded is solid at 17 million vs. the 10 day average of 21 million, options traders are quite active on the day, trading more than 672,970 options with 476,002 being calls and 196,968 being puts. This comes out to about 7 out of every 10 options being calls (image below).\n\nWhat It Matters:Prior to this Friday, there were 1,519,000 calls and 1,207,750 puts for a total of 2,726,000 options. Hence this Friday's options activity and flows of 672,970 comprise 25% of the total option flows out there.\nAny time a stock trades 25% of its total options in one day, it means options traders are particularly active in the stock.\nOf note, only 11% of the options were set to expire this Friday (~300,000 options) so today's 672,970 options suggest a lot more forward-looking flows.\nWhat's Next:Looking at the option flows expiring next week on Nov. 19, you can see on the call side the majority of volume and open interest is between the $330 and $360 strikes. And on the put side, there is a consistent but small volume between the $340 and $300 strikes (image below).\n\nThis suggests bullish traders are targeting between $330 and $360, but don't have much appetite above that. Meanwhile, bearish options traders don't see much downside below $300.\nIt should be noted the steady volume of puts from $340 to $300 appears to be a mix of bullish traders selling cash-secured puts down to the $322.5 strike, but likely long stock traders seeking protection below that as the premium is very low.\nHence bullish traders will want to see the $360 strike cleared by next week to lift their expectations higher while bears will want to see a weekly close below $300 to open up the downside.","news_type":1},"isVote":1,"tweetType":1,"viewCount":289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879441887,"gmtCreate":1636767657873,"gmtModify":1636767657873,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879441887","repostId":"1169510701","repostType":4,"repost":{"id":"1169510701","pubTimestamp":1636759821,"share":"https://www.laohu8.com/m/news/1169510701?lang=&edition=full","pubTime":"2021-11-13 07:30","market":"us","language":"en","title":"Buy the Elon Musk Dip in Tesla Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=1169510701","media":"TheStreet","summary":"Tesla stock has been incredibly volatile over the past week. Here's how to trade it as CEO Elon Musk","content":"<p>Tesla stock has been incredibly volatile over the past week. Here's how to trade it as CEO Elon Musk continues to sell.</p>\n<p>Tesla&nbsp;shares have been incredibly volatile this week. The stock fell 2.8% on Friday as investors try to sort out the next direction.</p>\n<p>Amid the recent slide — and perhaps one could say it triggered the decline — is CEO&nbsp;Elon Musk’s recent selling.</p>\n<p>Over the weekend, Musk ran a Twitter&nbsp;pollasking if he should sellsome of his shares.</p>\n<p>That led to a near-5% decline in Monday’s session, followed by a 12% haircut on Tuesday.</p>\n<p>He had sold more than&nbsp;$5 billion worth of stock&nbsp;earlier this week. Another $650 million&nbsp;was reported this morning.</p>\n<p>Referencing when I said “perhaps” Musk caused the recent selloff, many will say that is indeed the case and there’s no need to leave it to question.</p>\n<p>That may be true in some regards, but the stock shifted into a parabolic state this quarter.</p>\n<p>From Oct. 25 to the Nov. 4 high — covering just nine trading sessions — shares gained more than 30%.</p>\n<p>From Oct. 1 to those highs, the gain swells to almost 63%, while the run from the Aug. 17 low made less than three months sit at more than 91%.</p>\n<p>In other words, yes, the Musk headlines may have triggered the selling. But after such a meteoric run and after garnering a $1.2 trillion valuation near the high, Tesla stock was due for a correction regardless of which headline caused it.</p>\n<p><b>Trading Tesla Stock</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d6b8cde52218f9b3a6d0598de04b7a6b\" tg-width=\"1023\" tg-height=\"735\" width=\"100%\" height=\"auto\"><span>Daily chart of Tesla stock.</span></p>\n<p>Look at how wobbly this name has been, as the volatility and headline risks have ramped up over that past few days.</p>\n<p>We’ll likely see some “chest-pounding” by the Tesla bears, but don’t let them fool you — this stock has been explosive on the upside. The stock is up 150% over the past year and up over 1,300% over the past three years.</p>\n<p>As one of the few U.S. companies to&nbsp;hit a $1 trillion market cap, it’s perhaps the furthest thing from “TeslaQ” one could imagine.</p>\n<p>Despite the run, bulls are trying to buy the dip. Shares bounced hard at the 21-day moving average, but are threatening to lose that measure today.</p>\n<p>If it does, this week’s low near $987 is vulnerable. If Tesla breaks below it, the 10-week moving average could be in play. That’s followed by the $910 gap-fill and the 50-day moving average.</p>\n<p>On the upside, let’s see if Tesla can reclaim the 10-day moving average. A close over $1,100 repairs a lot of damage and opens up the $1,200 to $1,250 area.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy the Elon Musk Dip in Tesla Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy the Elon Musk Dip in Tesla Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 07:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/trading-tesla-tsla-stock-pullback-elon-musk-insider-selling><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla stock has been incredibly volatile over the past week. Here's how to trade it as CEO Elon Musk continues to sell.\nTesla shares have been incredibly volatile this week. The stock fell 2.8% on ...</p>\n\n<a href=\"https://www.thestreet.com/investing/trading-tesla-tsla-stock-pullback-elon-musk-insider-selling\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.thestreet.com/investing/trading-tesla-tsla-stock-pullback-elon-musk-insider-selling","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169510701","content_text":"Tesla stock has been incredibly volatile over the past week. Here's how to trade it as CEO Elon Musk continues to sell.\nTesla shares have been incredibly volatile this week. The stock fell 2.8% on Friday as investors try to sort out the next direction.\nAmid the recent slide — and perhaps one could say it triggered the decline — is CEO Elon Musk’s recent selling.\nOver the weekend, Musk ran a Twitter pollasking if he should sellsome of his shares.\nThat led to a near-5% decline in Monday’s session, followed by a 12% haircut on Tuesday.\nHe had sold more than $5 billion worth of stock earlier this week. Another $650 million was reported this morning.\nReferencing when I said “perhaps” Musk caused the recent selloff, many will say that is indeed the case and there’s no need to leave it to question.\nThat may be true in some regards, but the stock shifted into a parabolic state this quarter.\nFrom Oct. 25 to the Nov. 4 high — covering just nine trading sessions — shares gained more than 30%.\nFrom Oct. 1 to those highs, the gain swells to almost 63%, while the run from the Aug. 17 low made less than three months sit at more than 91%.\nIn other words, yes, the Musk headlines may have triggered the selling. But after such a meteoric run and after garnering a $1.2 trillion valuation near the high, Tesla stock was due for a correction regardless of which headline caused it.\nTrading Tesla Stock\nDaily chart of Tesla stock.\nLook at how wobbly this name has been, as the volatility and headline risks have ramped up over that past few days.\nWe’ll likely see some “chest-pounding” by the Tesla bears, but don’t let them fool you — this stock has been explosive on the upside. The stock is up 150% over the past year and up over 1,300% over the past three years.\nAs one of the few U.S. companies to hit a $1 trillion market cap, it’s perhaps the furthest thing from “TeslaQ” one could imagine.\nDespite the run, bulls are trying to buy the dip. Shares bounced hard at the 21-day moving average, but are threatening to lose that measure today.\nIf it does, this week’s low near $987 is vulnerable. If Tesla breaks below it, the 10-week moving average could be in play. That’s followed by the $910 gap-fill and the 50-day moving average.\nOn the upside, let’s see if Tesla can reclaim the 10-day moving average. A close over $1,100 repairs a lot of damage and opens up the $1,200 to $1,250 area.","news_type":1},"isVote":1,"tweetType":1,"viewCount":318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879443072,"gmtCreate":1636767539347,"gmtModify":1636767539347,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879443072","repostId":"1129004768","repostType":4,"isVote":1,"tweetType":1,"viewCount":290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847265676,"gmtCreate":1636525440667,"gmtModify":1636525494706,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"suspend","listText":"suspend","text":"suspend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847265676","repostId":"1102766884","repostType":4,"repost":{"id":"1102766884","pubTimestamp":1636515299,"share":"https://www.laohu8.com/m/news/1102766884?lang=&edition=full","pubTime":"2021-11-10 11:34","market":"hk","language":"en","title":"Keppel raises SPH bid to S$2.351 a share, cash component up by 20 cents; says price is final","url":"https://stock-news.laohu8.com/highlight/detail?id=1102766884","media":"The bussiness Times","summary":"Keppel Corp has upped its privatisation offer for Singapore Press Holdings (SPH) with a \"compelling\"","content":"<p>Keppel Corp has upped its privatisation offer for Singapore Press Holdings (SPH) with a \"compelling\" final offer of S$2.351 per share, which includes additional cash of S$0.20 per share.</p>\n<p>This comes after Cuscaden Peak - a consortium backed by Hotel Properties (HPL), businessman Ong Beng Seng, and two Temasek-linked entities, CLA Real Estate Holdings and Mapletree - made a counter bid for SPH in late October at S$2.10 per share in cash; or slightly higher than Keppel's original offer of S$2.099 per share.</p>\n<p>In a release to the Singapore Exchange late Tuesday night, Keppel beefed up the cash component of the offer by S$0.20 per share to S$0.868 per share. SPH shareholders will still receive 0.596 Keppel Reit units (valued at S$0.685 as at Nov 9) and 0.782 SPH Reit units (valued S$0.798 as at Nov 9) per SPH share.</p>\n<p>The revised offer implies a total equity value for SPH of S$3.8 billion.</p>\n<p>\"The cumulative value of SPH Reit and Keppel Reit units offered has increased by S$0.052/share with improving market conditions,\" Keppel said in the release.</p>\n<p>Keppel's initial offer comprised cash of S$0.668 per share, 0.596 Keppel Reit units (valued at S$0.715) and 0.782 SPH Reit units (valued at S$0.716) per share.</p>\n<p>Based on the <a href=\"https://laohu8.com/S/SPHEF\">SPH REIT</a> and Keppel REIT traded prices since the initial offer, the final offer implies a range of S$2.201-S$2.355/share. SPH shareholders will be receiving Keppel REIT units at a 10 per cent discount to its net asset value, Keppel also highlighted.</p>\n<p>Meanwhile, SPH and Keppel have entered into a supplemental letter to amend the implementation agreement and revise the terms of the scheme of arrangement.</p>\n<p>In a separate release, SPH - which publishes The Business Times - noted that the revised offer represents an improvement of 12 per cent over Keppel's original offer, as well as that of Cuscaden Peak's.</p>\n<p>It is a 57 per cent premium to the undisturbed trading price on March 30 and a 9 per cent premium to the last trading price on Nov 9.</p>\n<p>SPH said: \"Following Cuscaden Peak's announcement on Oct 29, SPH notified Keppel of the proposal and gave Keppel an opportunity to improve their current proposal. Keppel's revised scheme consideration is the outcome of SPH's engagement with Keppel to improve their proposal.\"</p>\n<p>Keppel highlighted that the final offer is \"firm and irrevocable\" with regulatory approvals obtained from MAS and the Foreign Investment Review Board (FIRB) of Australia.</p>\n<p>The higher cash consideration is expected to increase Keppel's pro forma net gearing post-transaction by 0.03x, with pro forma net gearing expected to remain below 1x.</p>\n<p>Subject to the approvals of both Keppel's and SPH's shareholders at their respective extraordinary general meetings slated for around Dec 8, as well as the sanction of the scheme by Singapore's High Court and the completion of SPH's media restructuring exercise, SPH shareholders can expect to receive the final consideration by mid January 2022.</p>\n<p>Loh Chin Hua, chief executive of Keppel Corporation, said: \"Taking into account improving global economic conditions as well as growing synergies which we have identified between Keppel and SPH's portfolio, Keppel is offering SPH shareholders a higher and final consideration of S$2.351/ share.\"</p>\n<p>He added: \"Even with the additional cash consideration of S$0.200/share, we continue to see value in the SPH portfolio.\"</p>\n<p>Shares in Keppel shed three cents to close at S$5.31, while shares in SPH closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> cent higher at S$2.16 on Tuesday.</p>","source":"lsy1636420184263","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Keppel raises SPH bid to S$2.351 a share, cash component up by 20 cents; says price is final</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKeppel raises SPH bid to S$2.351 a share, cash component up by 20 cents; says price is final\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 11:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/companies-markets/keppel-raises-sph-bid-to-s2351-a-share-cash-component-up-by-20-cents-says-price-is><strong>The bussiness Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Keppel Corp has upped its privatisation offer for Singapore Press Holdings (SPH) with a \"compelling\" final offer of S$2.351 per share, which includes additional cash of S$0.20 per share.\nThis comes ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/companies-markets/keppel-raises-sph-bid-to-s2351-a-share-cash-component-up-by-20-cents-says-price-is\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BN4.SI":"吉宝有限公司"},"source_url":"https://www.businesstimes.com.sg/companies-markets/keppel-raises-sph-bid-to-s2351-a-share-cash-component-up-by-20-cents-says-price-is","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102766884","content_text":"Keppel Corp has upped its privatisation offer for Singapore Press Holdings (SPH) with a \"compelling\" final offer of S$2.351 per share, which includes additional cash of S$0.20 per share.\nThis comes after Cuscaden Peak - a consortium backed by Hotel Properties (HPL), businessman Ong Beng Seng, and two Temasek-linked entities, CLA Real Estate Holdings and Mapletree - made a counter bid for SPH in late October at S$2.10 per share in cash; or slightly higher than Keppel's original offer of S$2.099 per share.\nIn a release to the Singapore Exchange late Tuesday night, Keppel beefed up the cash component of the offer by S$0.20 per share to S$0.868 per share. SPH shareholders will still receive 0.596 Keppel Reit units (valued at S$0.685 as at Nov 9) and 0.782 SPH Reit units (valued S$0.798 as at Nov 9) per SPH share.\nThe revised offer implies a total equity value for SPH of S$3.8 billion.\n\"The cumulative value of SPH Reit and Keppel Reit units offered has increased by S$0.052/share with improving market conditions,\" Keppel said in the release.\nKeppel's initial offer comprised cash of S$0.668 per share, 0.596 Keppel Reit units (valued at S$0.715) and 0.782 SPH Reit units (valued at S$0.716) per share.\nBased on the SPH REIT and Keppel REIT traded prices since the initial offer, the final offer implies a range of S$2.201-S$2.355/share. SPH shareholders will be receiving Keppel REIT units at a 10 per cent discount to its net asset value, Keppel also highlighted.\nMeanwhile, SPH and Keppel have entered into a supplemental letter to amend the implementation agreement and revise the terms of the scheme of arrangement.\nIn a separate release, SPH - which publishes The Business Times - noted that the revised offer represents an improvement of 12 per cent over Keppel's original offer, as well as that of Cuscaden Peak's.\nIt is a 57 per cent premium to the undisturbed trading price on March 30 and a 9 per cent premium to the last trading price on Nov 9.\nSPH said: \"Following Cuscaden Peak's announcement on Oct 29, SPH notified Keppel of the proposal and gave Keppel an opportunity to improve their current proposal. Keppel's revised scheme consideration is the outcome of SPH's engagement with Keppel to improve their proposal.\"\nKeppel highlighted that the final offer is \"firm and irrevocable\" with regulatory approvals obtained from MAS and the Foreign Investment Review Board (FIRB) of Australia.\nThe higher cash consideration is expected to increase Keppel's pro forma net gearing post-transaction by 0.03x, with pro forma net gearing expected to remain below 1x.\nSubject to the approvals of both Keppel's and SPH's shareholders at their respective extraordinary general meetings slated for around Dec 8, as well as the sanction of the scheme by Singapore's High Court and the completion of SPH's media restructuring exercise, SPH shareholders can expect to receive the final consideration by mid January 2022.\nLoh Chin Hua, chief executive of Keppel Corporation, said: \"Taking into account improving global economic conditions as well as growing synergies which we have identified between Keppel and SPH's portfolio, Keppel is offering SPH shareholders a higher and final consideration of S$2.351/ share.\"\nHe added: \"Even with the additional cash consideration of S$0.200/share, we continue to see value in the SPH portfolio.\"\nShares in Keppel shed three cents to close at S$5.31, while shares in SPH closed one cent higher at S$2.16 on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845292823,"gmtCreate":1636338905216,"gmtModify":1636338905304,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/845292823","repostId":"2181284457","repostType":4,"isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851538380,"gmtCreate":1634913640847,"gmtModify":1634913640910,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851538380","repostId":"1127948887","repostType":4,"repost":{"id":"1127948887","pubTimestamp":1634911022,"share":"https://www.laohu8.com/m/news/1127948887?lang=&edition=full","pubTime":"2021-10-22 21:57","market":"us","language":"en","title":"US Manufacturing Survey Slumps To 7-Month-Low, Services Jump In October","url":"https://stock-news.laohu8.com/highlight/detail?id=1127948887","media":"zerohedge","summary":"Following September's slide (in both Services and Manufacturing), analysts expected preliminary Octo","content":"<p>Following September's slide (in both Services and Manufacturing), analysts expected preliminary October data to be more mixed with a slight gain for Services and very slight weakening for Manufacturing (which may be simply mimicking the rebound in ISM's survey in September).</p>\n<p>Despite the overall trend lower in US macro data, the PMI prints were indeed very mixed with Services surging from 54.9 to 58.2 (well above the 55.2 expected) while Manufacturing stumbled to 59.2 from 60.7 (worse than the 60.5 expected)...</p>\n<p><img src=\"https://static.tigerbbs.com/fa03967885abd270d631fef7ca7cbb9b\" tg-width=\"994\" tg-height=\"566\" referrerpolicy=\"no-referrer\"><i>Source: Bloomberg</i></p>\n<p>That is the weakest Manufacturing print since March and strongest Services in 3 months.</p>\n<p>Under the hood, the<b>latest rise in factory production was the softest since July 2020.</b></p>\n<p>October data also highlighted stronger inflationary pressures across the US economy.<b>Average input prices rose at a survey record pace,</b>with firms attributing higher costs to supply issues, material shortages, greater transport fees and increased wage bills. Subsequently, the rate of selling price inflation for goods and services also hit a new series peak.</p>\n<p>The big gain in Services pushed the US Composite up to 57.3 (from 55.0) and back in the lead on a global basis...</p>\n<p><img src=\"https://static.tigerbbs.com/fc861b2a2fa3f22931acaac889e68f8a\" tg-width=\"994\" tg-height=\"564\" referrerpolicy=\"no-referrer\"><i>Source: Bloomberg</i></p>\n<p>Commenting on the PMI data,Chris Williamson, Chief Business Economist at IHS Markit, said:</p>\n<blockquote>\n “ \n <b>October saw resurgent service sector activity as COVID-19 case numbers continued to fall, marking a encouragingly strong start to the fourth quarter for the economy.</b>Hiring has likewise picked up as firms have been encouraged to expand capacity to meet rising demand.\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/704193861138e841e6b428314302c463\" tg-width=\"591\" tg-height=\"455\" referrerpolicy=\"no-referrer\">“However, while manufacturers also continue to report strong demand,<b>factory production remains plagued by constraints, including record supply chain bottlenecks and labor shortages.</b>Prices paid by factories for raw materials rose at yet another new record pace as a result, in turn feeding through to both higher prices at the factory gate and spilling over into higher service sector prices. Higher wages are also having to be offered to attract or retain staff, adding to the inflationary pressures.</p>\n<blockquote>\n “Thus, while the economy looks set for stronger growth in the fourth quarter, \n <b>the upward rise in inflationary pressures also shows no signs of abating.</b>”\n</blockquote>\n<p>So not transitory then?</p>\n<p></p>","source":"lsy1583725640930","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US Manufacturing Survey Slumps To 7-Month-Low, Services Jump In October</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS Manufacturing Survey Slumps To 7-Month-Low, Services Jump In October\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 21:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/economics/us-manufacturing-survey-slumps-7-month-low-services-jump-october?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Following September's slide (in both Services and Manufacturing), analysts expected preliminary October data to be more mixed with a slight gain for Services and very slight weakening for ...</p>\n\n<a href=\"https://www.zerohedge.com/economics/us-manufacturing-survey-slumps-7-month-low-services-jump-october?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"source_url":"https://www.zerohedge.com/economics/us-manufacturing-survey-slumps-7-month-low-services-jump-october?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127948887","content_text":"Following September's slide (in both Services and Manufacturing), analysts expected preliminary October data to be more mixed with a slight gain for Services and very slight weakening for Manufacturing (which may be simply mimicking the rebound in ISM's survey in September).\nDespite the overall trend lower in US macro data, the PMI prints were indeed very mixed with Services surging from 54.9 to 58.2 (well above the 55.2 expected) while Manufacturing stumbled to 59.2 from 60.7 (worse than the 60.5 expected)...\nSource: Bloomberg\nThat is the weakest Manufacturing print since March and strongest Services in 3 months.\nUnder the hood, thelatest rise in factory production was the softest since July 2020.\nOctober data also highlighted stronger inflationary pressures across the US economy.Average input prices rose at a survey record pace,with firms attributing higher costs to supply issues, material shortages, greater transport fees and increased wage bills. Subsequently, the rate of selling price inflation for goods and services also hit a new series peak.\nThe big gain in Services pushed the US Composite up to 57.3 (from 55.0) and back in the lead on a global basis...\nSource: Bloomberg\nCommenting on the PMI data,Chris Williamson, Chief Business Economist at IHS Markit, said:\n\n “ \n October saw resurgent service sector activity as COVID-19 case numbers continued to fall, marking a encouragingly strong start to the fourth quarter for the economy.Hiring has likewise picked up as firms have been encouraged to expand capacity to meet rising demand.\n\n“However, while manufacturers also continue to report strong demand,factory production remains plagued by constraints, including record supply chain bottlenecks and labor shortages.Prices paid by factories for raw materials rose at yet another new record pace as a result, in turn feeding through to both higher prices at the factory gate and spilling over into higher service sector prices. Higher wages are also having to be offered to attract or retain staff, adding to the inflationary pressures.\n\n “Thus, while the economy looks set for stronger growth in the fourth quarter, \n the upward rise in inflationary pressures also shows no signs of abating.”\n\nSo not transitory then?","news_type":1},"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":875274018,"gmtCreate":1637663847626,"gmtModify":1637663847626,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875274018","repostId":"1100407650","repostType":4,"repost":{"id":"1100407650","pubTimestamp":1637663293,"share":"https://www.laohu8.com/m/news/1100407650?lang=&edition=full","pubTime":"2021-11-23 18:28","market":"hk","language":"en","title":"Xiaomi revenue misses estimates as competition intensifies","url":"https://stock-news.laohu8.com/highlight/detail?id=1100407650","media":"Reuters","summary":"SHANGHAI, Nov 23 (Reuters) - Chinese smartphone maker Xiaomi Corp(1810.HK)on Tuesday reported a smal","content":"<p>SHANGHAI, Nov 23 (Reuters) - Chinese smartphone maker Xiaomi Corp(1810.HK)on Tuesday reported a smaller than expected 8.2% rise in third-quarter revenue, hurt by intensifying competition from domestic rivals Oppo and Vivo.</p>\n<p>Sales rose to 78.06 billion yuan ($12.22 billion) in the three months to Sept. 30. Analysts had expected 79.20 billion yuan, Refinitiv data shows.</p>\n<p>Profit slumped 84% to 788.6 million yuan.</p>\n<p>On an adjusted basis, Xiaomi earned 5.18 billion yuan, largely in line with the average analyst expectations for 5.09 billion yuan.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xiaomi revenue misses estimates as competition intensifies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXiaomi revenue misses estimates as competition intensifies\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-23 18:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/media-telecom/xiaomi-q3-revenue-up-82-year-on-year-7806-bln-yuan-misses-estimtes-2021-11-23/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SHANGHAI, Nov 23 (Reuters) - Chinese smartphone maker Xiaomi Corp(1810.HK)on Tuesday reported a smaller than expected 8.2% rise in third-quarter revenue, hurt by intensifying competition from domestic...</p>\n\n<a href=\"https://www.reuters.com/business/media-telecom/xiaomi-q3-revenue-up-82-year-on-year-7806-bln-yuan-misses-estimtes-2021-11-23/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01810":"小米集团-W"},"source_url":"https://www.reuters.com/business/media-telecom/xiaomi-q3-revenue-up-82-year-on-year-7806-bln-yuan-misses-estimtes-2021-11-23/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100407650","content_text":"SHANGHAI, Nov 23 (Reuters) - Chinese smartphone maker Xiaomi Corp(1810.HK)on Tuesday reported a smaller than expected 8.2% rise in third-quarter revenue, hurt by intensifying competition from domestic rivals Oppo and Vivo.\nSales rose to 78.06 billion yuan ($12.22 billion) in the three months to Sept. 30. Analysts had expected 79.20 billion yuan, Refinitiv data shows.\nProfit slumped 84% to 788.6 million yuan.\nOn an adjusted basis, Xiaomi earned 5.18 billion yuan, largely in line with the average analyst expectations for 5.09 billion yuan.","news_type":1},"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879443072,"gmtCreate":1636767539347,"gmtModify":1636767539347,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879443072","repostId":"1129004768","repostType":4,"repost":{"id":"1129004768","pubTimestamp":1636764434,"share":"https://www.laohu8.com/m/news/1129004768?lang=&edition=full","pubTime":"2021-11-13 08:47","market":"us","language":"en","title":"Apple: The Bear Argument, And Why It's Wrong","url":"https://stock-news.laohu8.com/highlight/detail?id=1129004768","media":"Seeking Alpha","summary":"Apple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.I list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.Maybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.This may also help to explain, in part, why Apple's revenues in Greater China shot through the","content":"<p><b>Summary</b></p>\n<ul>\n <li>Apple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.</li>\n <li>I list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.</li>\n <li>Maybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4bc955cc5d27328c3b89b327b9368d27\" tg-width=\"1536\" tg-height=\"1020\" width=\"100%\" height=\"auto\"><span>kmwphotography/iStock via Getty Images</span></p>\n<p>With Apple (AAPL) once again failing to make fresh all-time highs, now down around 6% from the peak and dipping closer towards key moving-average support, bears have started to pay attention. Still, I think that the case for selling (or shorting) this stock does not hold much water in the long term, and I believe that bears will ultimately tire of swimming against the current.</p>\n<p>Below, I list the most common few reasons why one might want to dump or stay away from Apple shares – and why I think that the bearish case is either short-sighted or most likely incorrect.</p>\n<p><b>Key risk #1: drop-off in demand</b></p>\n<p>Not many analysts and portfolio managers have been vocal about avoiding or selling Apple. Experts like New Street's&nbsp;Pierre Ferragu&nbsp;and Satori Fund's&nbsp;Dan Niles&nbsp;are the few that come to mind, and their theses seem to align pretty well with every other bearish call on AAPL that I have seen recently.</p>\n<p>The first common reason to sell the stock is often phrased in different ways, but can effectively be summarized as follows: Apple's financial results in the near term should suffer from demand that has already turned into revenues in calendar 2020, during the thick of the pandemic and stay-at-home consumption wave. This is particularly true following the launch of the iPhone 13 that some (including legendary Apple founder&nbsp;Steve Wozniak) see as merely a minor upgrade from the previous model.</p>\n<p>I see the concern here, especially considering that Apple will start to face unsurmountable iPhone comps in the holidays and post-holiday quarters – see graph below. But the same chart also shows that there seemed to exist quite a bit of pent-up demand over the many quarters that preceded the iPhone 12 launch. One possible justification for this shift in sales from fiscal 2019-2020 to 2021 is Apple's late entry into the 5G space. Consumers that are loyal to or just prefer the iOS device probably waited patiently to upgrade or switch, and then they did it all at once.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7dc677f0a1c77dd39f40b4cc99c6fc15\" tg-width=\"460\" tg-height=\"322\" width=\"100%\" height=\"auto\"><span>Source: DM Martins Research, data from company reports</span></p>\n<p>This may also help to explain, in part, why Apple's revenues in Greater China shot through the roof in the past 6 to 12 months. With the country's 5G infrastructure being further developed, owning a device that can handle the faster speeds probably makes most sense. Sales in the region had been lackluster to say the least since 2015, and dropped YOY by as much as 29% in fiscal Q4 of 2020. In the past three quarters, however, revenues climbed by at least 57% in each period.</p>\n<p>In the end, over the last 12 quarters – i.e. roughly the useful life of the average iPhone – Apple's smartphone sales have risen by only 4.8% per year. Considering that ASP (average selling price) has likely increased during the period, this figure barely represents any meaningful growth in device shipments over a full cycle. Therefore, to think that demand for Apple's products will fall off a cliff next seems like a stretch, especially if one also considers chip innovation and design updates in Mac and iPad.</p>\n<p><b>Key risk #2: valuation</b></p>\n<p>The other key risk of investing in Apple that is often brought up is valuation. Dan Niles, mentioned above, suggests that a next-year P/E of 26 times might not even be the biggest deal. The problem is that this multiple looks too rich against growth expectations that are modest.Analysts expect Apple's EPS&nbsp;to rise by only 4% per year through fiscal 2025. Alphabet (GOOG)(GOOGL), valued at a similar earnings multiple, is expected to drive earnings 16% higher per year over a similar period.</p>\n<p>That, in my view, is a more reasonable bearish argument. Per my estimates, Apple is by far the stock with the highest PEG ratio (P/E over long-term EPS growth) of 6.5 times. Amazon (AMZN) is a very distant second on this metric, at 2.3 times. But even here, I see a good argument to be made in favor of Apple.</p>\n<p>First, the company has been proving to be a powerful gatekeeper in the tech world. Here is one example: the first, most blatant sign that Apple's iOS privacy policy changes in the summer&nbsp;have been hurting social media companies&nbsp;and their financial statements&nbsp;led to the Nasdaqe&nbsp;rasing $120 billion in market value in a matter of minutes – most of which coming from internet stocks. Should one be expected to pay a premium for a stock in the face of such market control? I would say so.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0946db3f3bc62569a56f2dbe2aa75922\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>Also, as the chart above depicts, Apple's forward-year P/E has certainly expanded relative to what it used to be a few years ago. But the multi-year move higher seems consistent with (1) a wave of increased demand for Apple's products and services, (2) better margins, (3) a drop in interest rates in 2020, and (4) a broad stock market that has become generally more expensive. Compared to how AAPL traded only about three months ago, P/E has in fact dipped about three turns and returned to early 2021 levels.</p>\n<p><b>Key risk #3: lack of positive catalysts</b></p>\n<p>The next risk to investing in Apple that is often cited are short-term catalysts. The iPhone 13 was announced a few weeks ago, and&nbsp;so has the refreshed lineup&nbsp;of MacBook Pro devices equipped with the new M1 Pro and Max chips. Fiscal fourth quarter earnings is also in the rearview mirror. In fact, I think that the drop off in relevant Apple news in the fourth quarter correlates well with a stock that, seasonally, tends to perform worse in the November-to-January period. Bears may also argue that, with a few quarters of tough comps ahead, investors might have a hard time finding reasons to buy AAPL in the next few months.</p>\n<p>But here, I believe that a bit of patience is warranted. First, the recent malaise in share price alone may be enough to attract new money from investors looking for a good deal on a high-quality stock. But more importantly, longer-term catalysts are likely to make more of a difference on share price and financial performance over the next, say, five years.</p>\n<p>I have previously talked in more detail about two catalysts that quickly come to mind. I doubt that much upside from initiatives like mixed reality and&nbsp;autonomous vehicle&nbsp;has been factored into analysts' financial models – and hence, properly priced into the stock. Because Apple is run by a conservative team of executives, I bet that both massive growth opportunities will be pursued if and when they are accretive to the company's earnings. They should, therefore, serve as the key catalysts driving long-term growth expectations (which is relevant for risk #1 above) and share price higher.</p>\n<p><b>In summary</b></p>\n<p>Apple may not be the same pound-the-table opportunity that I believed it to be&nbsp;in February 2021&nbsp;or, better yet,in April 2018&nbsp;– in both cases, I believed that shares had sold off for no good reason. But I continue to think that AAPL is a stock to own today through the next several years, especially now that the earnings multiple has started to rerate towards year-ago levels. Should Apple continue to head lower in the near term, the pullback (assuming no meaningful change in business fundamentals) would present an even better chance to buy.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: The Bear Argument, And Why It's Wrong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: The Bear Argument, And Why It's Wrong\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.\nI list a couple of the most popular bearish arguments, and ...</p>\n\n<a href=\"https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129004768","content_text":"Summary\n\nApple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.\nI list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.\nMaybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.\n\nkmwphotography/iStock via Getty Images\nWith Apple (AAPL) once again failing to make fresh all-time highs, now down around 6% from the peak and dipping closer towards key moving-average support, bears have started to pay attention. Still, I think that the case for selling (or shorting) this stock does not hold much water in the long term, and I believe that bears will ultimately tire of swimming against the current.\nBelow, I list the most common few reasons why one might want to dump or stay away from Apple shares – and why I think that the bearish case is either short-sighted or most likely incorrect.\nKey risk #1: drop-off in demand\nNot many analysts and portfolio managers have been vocal about avoiding or selling Apple. Experts like New Street's Pierre Ferragu and Satori Fund's Dan Niles are the few that come to mind, and their theses seem to align pretty well with every other bearish call on AAPL that I have seen recently.\nThe first common reason to sell the stock is often phrased in different ways, but can effectively be summarized as follows: Apple's financial results in the near term should suffer from demand that has already turned into revenues in calendar 2020, during the thick of the pandemic and stay-at-home consumption wave. This is particularly true following the launch of the iPhone 13 that some (including legendary Apple founder Steve Wozniak) see as merely a minor upgrade from the previous model.\nI see the concern here, especially considering that Apple will start to face unsurmountable iPhone comps in the holidays and post-holiday quarters – see graph below. But the same chart also shows that there seemed to exist quite a bit of pent-up demand over the many quarters that preceded the iPhone 12 launch. One possible justification for this shift in sales from fiscal 2019-2020 to 2021 is Apple's late entry into the 5G space. Consumers that are loyal to or just prefer the iOS device probably waited patiently to upgrade or switch, and then they did it all at once.\nSource: DM Martins Research, data from company reports\nThis may also help to explain, in part, why Apple's revenues in Greater China shot through the roof in the past 6 to 12 months. With the country's 5G infrastructure being further developed, owning a device that can handle the faster speeds probably makes most sense. Sales in the region had been lackluster to say the least since 2015, and dropped YOY by as much as 29% in fiscal Q4 of 2020. In the past three quarters, however, revenues climbed by at least 57% in each period.\nIn the end, over the last 12 quarters – i.e. roughly the useful life of the average iPhone – Apple's smartphone sales have risen by only 4.8% per year. Considering that ASP (average selling price) has likely increased during the period, this figure barely represents any meaningful growth in device shipments over a full cycle. Therefore, to think that demand for Apple's products will fall off a cliff next seems like a stretch, especially if one also considers chip innovation and design updates in Mac and iPad.\nKey risk #2: valuation\nThe other key risk of investing in Apple that is often brought up is valuation. Dan Niles, mentioned above, suggests that a next-year P/E of 26 times might not even be the biggest deal. The problem is that this multiple looks too rich against growth expectations that are modest.Analysts expect Apple's EPS to rise by only 4% per year through fiscal 2025. Alphabet (GOOG)(GOOGL), valued at a similar earnings multiple, is expected to drive earnings 16% higher per year over a similar period.\nThat, in my view, is a more reasonable bearish argument. Per my estimates, Apple is by far the stock with the highest PEG ratio (P/E over long-term EPS growth) of 6.5 times. Amazon (AMZN) is a very distant second on this metric, at 2.3 times. But even here, I see a good argument to be made in favor of Apple.\nFirst, the company has been proving to be a powerful gatekeeper in the tech world. Here is one example: the first, most blatant sign that Apple's iOS privacy policy changes in the summer have been hurting social media companies and their financial statements led to the Nasdaqe rasing $120 billion in market value in a matter of minutes – most of which coming from internet stocks. Should one be expected to pay a premium for a stock in the face of such market control? I would say so.\nData by YCharts\nAlso, as the chart above depicts, Apple's forward-year P/E has certainly expanded relative to what it used to be a few years ago. But the multi-year move higher seems consistent with (1) a wave of increased demand for Apple's products and services, (2) better margins, (3) a drop in interest rates in 2020, and (4) a broad stock market that has become generally more expensive. Compared to how AAPL traded only about three months ago, P/E has in fact dipped about three turns and returned to early 2021 levels.\nKey risk #3: lack of positive catalysts\nThe next risk to investing in Apple that is often cited are short-term catalysts. The iPhone 13 was announced a few weeks ago, and so has the refreshed lineup of MacBook Pro devices equipped with the new M1 Pro and Max chips. Fiscal fourth quarter earnings is also in the rearview mirror. In fact, I think that the drop off in relevant Apple news in the fourth quarter correlates well with a stock that, seasonally, tends to perform worse in the November-to-January period. Bears may also argue that, with a few quarters of tough comps ahead, investors might have a hard time finding reasons to buy AAPL in the next few months.\nBut here, I believe that a bit of patience is warranted. First, the recent malaise in share price alone may be enough to attract new money from investors looking for a good deal on a high-quality stock. But more importantly, longer-term catalysts are likely to make more of a difference on share price and financial performance over the next, say, five years.\nI have previously talked in more detail about two catalysts that quickly come to mind. I doubt that much upside from initiatives like mixed reality and autonomous vehicle has been factored into analysts' financial models – and hence, properly priced into the stock. Because Apple is run by a conservative team of executives, I bet that both massive growth opportunities will be pursued if and when they are accretive to the company's earnings. They should, therefore, serve as the key catalysts driving long-term growth expectations (which is relevant for risk #1 above) and share price higher.\nIn summary\nApple may not be the same pound-the-table opportunity that I believed it to be in February 2021 or, better yet,in April 2018 – in both cases, I believed that shares had sold off for no good reason. But I continue to think that AAPL is a stock to own today through the next several years, especially now that the earnings multiple has started to rerate towards year-ago levels. Should Apple continue to head lower in the near term, the pullback (assuming no meaningful change in business fundamentals) would present an even better chance to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600027311,"gmtCreate":1638015721292,"gmtModify":1638015722167,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600027311","repostId":"2186344334","repostType":4,"isVote":1,"tweetType":1,"viewCount":638,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845292823,"gmtCreate":1636338905216,"gmtModify":1636338905304,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/845292823","repostId":"2181284457","repostType":4,"isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691727610,"gmtCreate":1640248731342,"gmtModify":1640248731527,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691727610","repostId":"2193423197","repostType":4,"repost":{"id":"2193423197","pubTimestamp":1640246313,"share":"https://www.laohu8.com/m/news/2193423197?lang=&edition=full","pubTime":"2021-12-23 15:58","market":"us","language":"en","title":"Buying Rivian Could Be Your Biggest Regret in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2193423197","media":"Motley Fool","summary":"The hype around this electric vehicle startup could be setting up investors for a massive let-down.","content":"<p>Electric vehicle start-up <b>Rivian Automotive</b>'s (NASDAQ:RIVN) November debut on Wall Street was <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the most hyped initial public offerings in recent memory. Its market cap is already more than $80 billion, and shareholders are hoping it becomes the next <b>Tesla&nbsp;</b>(NASDAQ:TSLA).</p>\n<p>With high demand for its upcoming vehicles and a large deal to supply vans to <b>Amazon</b>, Rivian could be a long-term winner. However, based on several short-term red flags, investors might wind up disappointed with the company in 2022.</p>\n<h2>Growing pains</h2>\n<p>Rivian doesn't have a demand problem, as evidenced by the 71,000 pre-orders it reported for its R1 models and a 100,000-vehicle order that it has from Amazon for delivery vans. But its investors need to consider just how difficult it is to develop the infrastructure required to mass-produce vehicles efficiently.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/78b644e16b6dbfb0376f73eb6f282745\" tg-width=\"700\" tg-height=\"405\" width=\"100%\" height=\"auto\"><span>Image source: Rivian Automotive.</span></p>\n<p>Tesla CEO Elon Musk once tweeted that \"the machine that makes the machine is vastly harder than the machine itself.\" In other words, designing and building one car is far easier than setting up assembly lines that can churn out hundreds of thousands of them.</p>\n<p>In the third quarter, Tesla produced 237,823 vehicles, so its annual vehicle production run rate is still under a million nearly a decade after it launched the Model S. Rivian can have all the pre-orders and demand it wants, but those won't translate into revenue until it builds and delivers the vehicles. Difficulties with its production ramp-up could hinder the EV company's growth over the next several years.</p>\n<p>In Rivian's Q3 shareholder letter, the company noted that it had produced a total of 652 R1 vehicles. Management also said that despite having the installed capacity to manufacture 150,000 cars a year at its factory, it would fall \"a few hundred\" units short of its 1,200 vehicle production goal for 2021. Again, building complex systems for automotive production is hard. It's possible that it&nbsp; could be several years before Rivian dramatically increases its production rate.</p>\n<h2>Increasing vehicle production will also be expensive</h2>\n<p>Rivian's efforts to ramp up production could significantly impact its financials. Right now, the balance sheet is well stocked; if you consider all of the proceeds from its initial public offering, it has almost $20 billion in cash on hand. Meanwhile, the company burned through about $1.5 billion on operating activities in the first nine months of the year. Based on those figures, one might expect that $20 billion would be enough to support Rivian for years.</p>\n<p>However, it could go through that cash stockpile faster than you'd think. Building vehicles is expensive. Automakers become profitable by eventually reaching a high enough production level that revenue begins to outrun the costs. The chart below illustrates how long it took Tesla to accomplish this. As the company initially began producing more and more cars, it spent more money, with its free cash flow deficits peaking in 2017-2018.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c6d44664a3823db77d9807bbb0d4c977\" tg-width=\"720\" tg-height=\"463\" width=\"100%\" height=\"auto\"><span>TSLA Revenue (TTM) data by YCharts</span></p>\n<p>Now, Rivian is investing heavily in expanding production, including labor, machinery, and new factories. It announced plans to build its second factory, beginning in 2022, with an estimated cost of $5 billion. Rivian may need to raise more money down the road to cover those expenses, which could dilute its shareholders if it does so by issuing additional stock.</p>\n<h2>The valuation is pricing in a lot of optimism</h2>\n<p>Tesla has been such an outstanding stock for long-term shareholders because it spent years as the underdog. Many people thought the company would fail. As recently as January 2020, Tesla's market cap was roughly $120 billion -- and it delivered $31.5 billion in revenue that year.</p>\n<p>Rivian might not even hit $100 million in revenue this year, but it's already valued at $85 billion. Meanwhile, it still needs to prove that it can successfully execute and achieve all of the milestones that investors are essentially giving it credit for in advance.</p>\n<p>In this high-inflation environment where investors are selling off speculative stocks in part due to concerns about rising interest rates, Rivian is the type of stock that could be vulnerable. It's not that it can't be a great company. It just isn't one yet, and the market is pricing it like the war is already won. In reality, Rivian hasn't even started the real battles yet. Investors should keep that in mind when considering this stock.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buying Rivian Could Be Your Biggest Regret in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuying Rivian Could Be Your Biggest Regret in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 15:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/22/buying-rivian-could-be-your-biggest-regret-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Electric vehicle start-up Rivian Automotive's (NASDAQ:RIVN) November debut on Wall Street was one of the most hyped initial public offerings in recent memory. Its market cap is already more than $80 ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/22/buying-rivian-could-be-your-biggest-regret-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","BK4099":"汽车制造商"},"source_url":"https://www.fool.com/investing/2021/12/22/buying-rivian-could-be-your-biggest-regret-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193423197","content_text":"Electric vehicle start-up Rivian Automotive's (NASDAQ:RIVN) November debut on Wall Street was one of the most hyped initial public offerings in recent memory. Its market cap is already more than $80 billion, and shareholders are hoping it becomes the next Tesla (NASDAQ:TSLA).\nWith high demand for its upcoming vehicles and a large deal to supply vans to Amazon, Rivian could be a long-term winner. However, based on several short-term red flags, investors might wind up disappointed with the company in 2022.\nGrowing pains\nRivian doesn't have a demand problem, as evidenced by the 71,000 pre-orders it reported for its R1 models and a 100,000-vehicle order that it has from Amazon for delivery vans. But its investors need to consider just how difficult it is to develop the infrastructure required to mass-produce vehicles efficiently.\nImage source: Rivian Automotive.\nTesla CEO Elon Musk once tweeted that \"the machine that makes the machine is vastly harder than the machine itself.\" In other words, designing and building one car is far easier than setting up assembly lines that can churn out hundreds of thousands of them.\nIn the third quarter, Tesla produced 237,823 vehicles, so its annual vehicle production run rate is still under a million nearly a decade after it launched the Model S. Rivian can have all the pre-orders and demand it wants, but those won't translate into revenue until it builds and delivers the vehicles. Difficulties with its production ramp-up could hinder the EV company's growth over the next several years.\nIn Rivian's Q3 shareholder letter, the company noted that it had produced a total of 652 R1 vehicles. Management also said that despite having the installed capacity to manufacture 150,000 cars a year at its factory, it would fall \"a few hundred\" units short of its 1,200 vehicle production goal for 2021. Again, building complex systems for automotive production is hard. It's possible that it  could be several years before Rivian dramatically increases its production rate.\nIncreasing vehicle production will also be expensive\nRivian's efforts to ramp up production could significantly impact its financials. Right now, the balance sheet is well stocked; if you consider all of the proceeds from its initial public offering, it has almost $20 billion in cash on hand. Meanwhile, the company burned through about $1.5 billion on operating activities in the first nine months of the year. Based on those figures, one might expect that $20 billion would be enough to support Rivian for years.\nHowever, it could go through that cash stockpile faster than you'd think. Building vehicles is expensive. Automakers become profitable by eventually reaching a high enough production level that revenue begins to outrun the costs. The chart below illustrates how long it took Tesla to accomplish this. As the company initially began producing more and more cars, it spent more money, with its free cash flow deficits peaking in 2017-2018.\nTSLA Revenue (TTM) data by YCharts\nNow, Rivian is investing heavily in expanding production, including labor, machinery, and new factories. It announced plans to build its second factory, beginning in 2022, with an estimated cost of $5 billion. Rivian may need to raise more money down the road to cover those expenses, which could dilute its shareholders if it does so by issuing additional stock.\nThe valuation is pricing in a lot of optimism\nTesla has been such an outstanding stock for long-term shareholders because it spent years as the underdog. Many people thought the company would fail. As recently as January 2020, Tesla's market cap was roughly $120 billion -- and it delivered $31.5 billion in revenue that year.\nRivian might not even hit $100 million in revenue this year, but it's already valued at $85 billion. Meanwhile, it still needs to prove that it can successfully execute and achieve all of the milestones that investors are essentially giving it credit for in advance.\nIn this high-inflation environment where investors are selling off speculative stocks in part due to concerns about rising interest rates, Rivian is the type of stock that could be vulnerable. It's not that it can't be a great company. It just isn't one yet, and the market is pricing it like the war is already won. In reality, Rivian hasn't even started the real battles yet. Investors should keep that in mind when considering this stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":657,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878782084,"gmtCreate":1637233583025,"gmtModify":1637233583025,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878782084","repostId":"1171955198","repostType":4,"repost":{"id":"1171955198","pubTimestamp":1637233373,"share":"https://www.laohu8.com/m/news/1171955198?lang=&edition=full","pubTime":"2021-11-18 19:02","market":"us","language":"en","title":"Starbucks, Amazon team up to open cashier-less store, cafe in NYC","url":"https://stock-news.laohu8.com/highlight/detail?id=1171955198","media":"Yahoo","summary":"Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in ","content":"<p>Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.</p>\n<p>The new Starbucks Pickup, located at 59th Street between Park &amp; Lexington Avenue, is set to open to the public on Thursday, November 18th. The retail experience uses the order ahead feature on the Starbucks app and Amazon Go’s Just Walk Out technology to create a touch-less experience, the companies announced on Thursday.</p>\n<p>The team-up is part of the ongoing COVID-19 era trend to leverage technology in favor of human contact to expedite requests, as well as reduce the chances of transmission.</p>\n<p>The two powerhouses are teaming up to create \"a common vision to provide innovative in-store experiences that are centered on the customer,” Dilip Kumar, Amazon's VP of physical retail and technology, said in a statement.</p>\n<p>Dubbed Starbucks Pickup with Amazon Go, the system gives customers the ability to choose their experience, \"whether it is utilizing the Starbucks and Amazon apps to purchase food and beverages on the go, or deciding to stay in the lounge for the traditional third place experience Starbucks is known for,” Starbucks executive Katie Young said.</p>\n<p>In order to enter the Amazon GO market and the store's lounge area, they must scan the \"In-Store Code\" in the Amazon Shopping app, Amazon One or a credit card. Once consumers enter the location, they can shop the market like any other Amazon Go location, grab their Starbucks mobile order and leave — or choose to stay a while.</p>\n<p>When guests take any item off the shelf, it will immediately be added to their virtual cart, and if customers put back an item, it will come out of the cart. Once the customer leaves the Amazon Go market portion of the store, their card will be charged and the receipt is expected to follow within a few hours, if not faster, according to the release.</p>\n<p>Items that will be available for pickup include classic Starbucks fare like Sous Vide Egg Bites, breakfast sandwiches and protein boxes, in addition to items that are found at other Amazon Go locations. Those include its Kitchen Turkey and Cheddar Sandwich, and the Buffalo-Style Wrap.</p>\n<p>In addition to that, the shelves will be stocked with well-known local favorites with items from Genji Sushi, York Street, Magnolia Bakery, Ess-a-bagel, among others.</p>\n<p>As Starbucks dives headfirst into digital and its&nbsp;loyalty program use soars, the companies plan to open at least three Starbucks Pickup with Amazon Go stores in total within the coming year, with the second location set to open in The New York Times Building located at 40th Street &amp; 8th Avenue.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starbucks, Amazon team up to open cashier-less store, cafe in NYC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarbucks, Amazon team up to open cashier-less store, cafe in NYC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html><strong>Yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.\nThe new Starbucks Pickup, located at 59th Street between ...</p>\n\n<a href=\"https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克","AMZN":"亚马逊"},"source_url":"https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171955198","content_text":"Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.\nThe new Starbucks Pickup, located at 59th Street between Park & Lexington Avenue, is set to open to the public on Thursday, November 18th. The retail experience uses the order ahead feature on the Starbucks app and Amazon Go’s Just Walk Out technology to create a touch-less experience, the companies announced on Thursday.\nThe team-up is part of the ongoing COVID-19 era trend to leverage technology in favor of human contact to expedite requests, as well as reduce the chances of transmission.\nThe two powerhouses are teaming up to create \"a common vision to provide innovative in-store experiences that are centered on the customer,” Dilip Kumar, Amazon's VP of physical retail and technology, said in a statement.\nDubbed Starbucks Pickup with Amazon Go, the system gives customers the ability to choose their experience, \"whether it is utilizing the Starbucks and Amazon apps to purchase food and beverages on the go, or deciding to stay in the lounge for the traditional third place experience Starbucks is known for,” Starbucks executive Katie Young said.\nIn order to enter the Amazon GO market and the store's lounge area, they must scan the \"In-Store Code\" in the Amazon Shopping app, Amazon One or a credit card. Once consumers enter the location, they can shop the market like any other Amazon Go location, grab their Starbucks mobile order and leave — or choose to stay a while.\nWhen guests take any item off the shelf, it will immediately be added to their virtual cart, and if customers put back an item, it will come out of the cart. Once the customer leaves the Amazon Go market portion of the store, their card will be charged and the receipt is expected to follow within a few hours, if not faster, according to the release.\nItems that will be available for pickup include classic Starbucks fare like Sous Vide Egg Bites, breakfast sandwiches and protein boxes, in addition to items that are found at other Amazon Go locations. Those include its Kitchen Turkey and Cheddar Sandwich, and the Buffalo-Style Wrap.\nIn addition to that, the shelves will be stocked with well-known local favorites with items from Genji Sushi, York Street, Magnolia Bakery, Ess-a-bagel, among others.\nAs Starbucks dives headfirst into digital and its loyalty program use soars, the companies plan to open at least three Starbucks Pickup with Amazon Go stores in total within the coming year, with the second location set to open in The New York Times Building located at 40th Street & 8th Avenue.","news_type":1},"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879441887,"gmtCreate":1636767657873,"gmtModify":1636767657873,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879441887","repostId":"1169510701","repostType":4,"repost":{"id":"1169510701","pubTimestamp":1636759821,"share":"https://www.laohu8.com/m/news/1169510701?lang=&edition=full","pubTime":"2021-11-13 07:30","market":"us","language":"en","title":"Buy the Elon Musk Dip in Tesla Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=1169510701","media":"TheStreet","summary":"Tesla stock has been incredibly volatile over the past week. Here's how to trade it as CEO Elon Musk","content":"<p>Tesla stock has been incredibly volatile over the past week. Here's how to trade it as CEO Elon Musk continues to sell.</p>\n<p>Tesla&nbsp;shares have been incredibly volatile this week. The stock fell 2.8% on Friday as investors try to sort out the next direction.</p>\n<p>Amid the recent slide — and perhaps one could say it triggered the decline — is CEO&nbsp;Elon Musk’s recent selling.</p>\n<p>Over the weekend, Musk ran a Twitter&nbsp;pollasking if he should sellsome of his shares.</p>\n<p>That led to a near-5% decline in Monday’s session, followed by a 12% haircut on Tuesday.</p>\n<p>He had sold more than&nbsp;$5 billion worth of stock&nbsp;earlier this week. Another $650 million&nbsp;was reported this morning.</p>\n<p>Referencing when I said “perhaps” Musk caused the recent selloff, many will say that is indeed the case and there’s no need to leave it to question.</p>\n<p>That may be true in some regards, but the stock shifted into a parabolic state this quarter.</p>\n<p>From Oct. 25 to the Nov. 4 high — covering just nine trading sessions — shares gained more than 30%.</p>\n<p>From Oct. 1 to those highs, the gain swells to almost 63%, while the run from the Aug. 17 low made less than three months sit at more than 91%.</p>\n<p>In other words, yes, the Musk headlines may have triggered the selling. But after such a meteoric run and after garnering a $1.2 trillion valuation near the high, Tesla stock was due for a correction regardless of which headline caused it.</p>\n<p><b>Trading Tesla Stock</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d6b8cde52218f9b3a6d0598de04b7a6b\" tg-width=\"1023\" tg-height=\"735\" width=\"100%\" height=\"auto\"><span>Daily chart of Tesla stock.</span></p>\n<p>Look at how wobbly this name has been, as the volatility and headline risks have ramped up over that past few days.</p>\n<p>We’ll likely see some “chest-pounding” by the Tesla bears, but don’t let them fool you — this stock has been explosive on the upside. The stock is up 150% over the past year and up over 1,300% over the past three years.</p>\n<p>As one of the few U.S. companies to&nbsp;hit a $1 trillion market cap, it’s perhaps the furthest thing from “TeslaQ” one could imagine.</p>\n<p>Despite the run, bulls are trying to buy the dip. Shares bounced hard at the 21-day moving average, but are threatening to lose that measure today.</p>\n<p>If it does, this week’s low near $987 is vulnerable. If Tesla breaks below it, the 10-week moving average could be in play. That’s followed by the $910 gap-fill and the 50-day moving average.</p>\n<p>On the upside, let’s see if Tesla can reclaim the 10-day moving average. A close over $1,100 repairs a lot of damage and opens up the $1,200 to $1,250 area.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy the Elon Musk Dip in Tesla Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy the Elon Musk Dip in Tesla Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 07:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/trading-tesla-tsla-stock-pullback-elon-musk-insider-selling><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla stock has been incredibly volatile over the past week. Here's how to trade it as CEO Elon Musk continues to sell.\nTesla shares have been incredibly volatile this week. The stock fell 2.8% on ...</p>\n\n<a href=\"https://www.thestreet.com/investing/trading-tesla-tsla-stock-pullback-elon-musk-insider-selling\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.thestreet.com/investing/trading-tesla-tsla-stock-pullback-elon-musk-insider-selling","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169510701","content_text":"Tesla stock has been incredibly volatile over the past week. Here's how to trade it as CEO Elon Musk continues to sell.\nTesla shares have been incredibly volatile this week. The stock fell 2.8% on Friday as investors try to sort out the next direction.\nAmid the recent slide — and perhaps one could say it triggered the decline — is CEO Elon Musk’s recent selling.\nOver the weekend, Musk ran a Twitter pollasking if he should sellsome of his shares.\nThat led to a near-5% decline in Monday’s session, followed by a 12% haircut on Tuesday.\nHe had sold more than $5 billion worth of stock earlier this week. Another $650 million was reported this morning.\nReferencing when I said “perhaps” Musk caused the recent selloff, many will say that is indeed the case and there’s no need to leave it to question.\nThat may be true in some regards, but the stock shifted into a parabolic state this quarter.\nFrom Oct. 25 to the Nov. 4 high — covering just nine trading sessions — shares gained more than 30%.\nFrom Oct. 1 to those highs, the gain swells to almost 63%, while the run from the Aug. 17 low made less than three months sit at more than 91%.\nIn other words, yes, the Musk headlines may have triggered the selling. But after such a meteoric run and after garnering a $1.2 trillion valuation near the high, Tesla stock was due for a correction regardless of which headline caused it.\nTrading Tesla Stock\nDaily chart of Tesla stock.\nLook at how wobbly this name has been, as the volatility and headline risks have ramped up over that past few days.\nWe’ll likely see some “chest-pounding” by the Tesla bears, but don’t let them fool you — this stock has been explosive on the upside. The stock is up 150% over the past year and up over 1,300% over the past three years.\nAs one of the few U.S. companies to hit a $1 trillion market cap, it’s perhaps the furthest thing from “TeslaQ” one could imagine.\nDespite the run, bulls are trying to buy the dip. Shares bounced hard at the 21-day moving average, but are threatening to lose that measure today.\nIf it does, this week’s low near $987 is vulnerable. If Tesla breaks below it, the 10-week moving average could be in play. That’s followed by the $910 gap-fill and the 50-day moving average.\nOn the upside, let’s see if Tesla can reclaim the 10-day moving average. A close over $1,100 repairs a lot of damage and opens up the $1,200 to $1,250 area.","news_type":1},"isVote":1,"tweetType":1,"viewCount":318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851538380,"gmtCreate":1634913640847,"gmtModify":1634913640910,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851538380","repostId":"1127948887","repostType":4,"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607595322,"gmtCreate":1639558142474,"gmtModify":1639558142604,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607595322","repostId":"1160618167","repostType":4,"repost":{"id":"1160618167","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639551825,"share":"https://www.laohu8.com/m/news/1160618167?lang=&edition=full","pubTime":"2021-12-15 15:03","market":"us","language":"en","title":"Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival","url":"https://stock-news.laohu8.com/highlight/detail?id=1160618167","media":"Benzinga","summary":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in t","content":"<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p>\n<p>Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p>\n<p>Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p>\n<p>Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p>\n<p>Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p>\n<p>Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p>\n<p>Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p>\n<p>The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p>\n<p>Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p>\n<p>ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p>\n<p><b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p>\n<p>The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p>\n<p>Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p>\n<p>Here are a few other key Ark trades from Tuesday:</p>\n<ul>\n <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>\n <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-15 15:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p>\n<p>Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p>\n<p>Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p>\n<p>Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p>\n<p>Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p>\n<p>Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p>\n<p>Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p>\n<p>The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p>\n<p>Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p>\n<p>ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p>\n<p><b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p>\n<p>The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p>\n<p>Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p>\n<p>Here are a few other key Ark trades from Tuesday:</p>\n<ul>\n <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>\n <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车","JD":"京东","ARKQ":"ARK Autonomous Technology & Robotics ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160618167","content_text":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker Xpeng Inc(NYSE:XPEV) on the dip.\nArk Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.\nXpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.\nXpeng and other Chinese peer shares such as Nio Inc(NYSE:NIO) have been under pressure recently.\nXpeng bolted ahead of local rivals Nio and Li Auto Inc(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.\nEach of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.\nXpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.\nThe maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.\nArk Invest bought shares in Xpeng via the ArkAutonomous Technology & Robotics ETF.\nARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.\nTesla Inc is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.\nThe investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.\nTesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.\nHere are a few other key Ark trades from Tuesday:\n\nBought 11,671 shares — estimated to be worth $3 million — in Coinbase Global Inc. The stock closed 1.79% higher at $255.86 a share on Tuesday.\nSold 56,925 shares — estimated to be worth $4.4 million — inJD.com Inc. The stock closed 0.51% lower at $77.65 a share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":434,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878786608,"gmtCreate":1637233487522,"gmtModify":1637233487522,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878786608","repostId":"1184486139","repostType":4,"repost":{"id":"1184486139","pubTimestamp":1637233157,"share":"https://www.laohu8.com/m/news/1184486139?lang=&edition=full","pubTime":"2021-11-18 18:59","market":"us","language":"en","title":"Earnings Scheduled For November 18, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1184486139","media":"Benzinga","summary":"Companies Reporting Before The Bell\n• Alibaba Group Holding (NYSE:BABA) is expected to report quarte","content":"<p>Companies Reporting Before The Bell</p>\n<p>• Alibaba Group Holding (NYSE:BABA) is expected to report quarterly earnings at $1.93 per share on revenue of $32.05 billion.</p>\n<p>• Mechel PAO (NYSE:MTL) is estimated to report earnings for its third quarter.</p>\n<p>• BioLine Rx (NASDAQ:BLRX) is projected to report earnings for its third quarter.</p>\n<p>• Children's Place (NASDAQ:PLCE) is projected to report earnings for its third quarter.</p>\n<p>• BIT Mining (NYSE:BTCM) is expected to report earnings for its third quarter.</p>\n<p>• Canadian Solar (NASDAQ:CSIQ) is estimated to report quarterly earnings at $0.18 per share on revenue of $1.33 billion.</p>\n<p>• BJ's Wholesale Club (NYSE:BJ) is projected to report quarterly earnings at $0.78 per share on revenue of $3.85 billion.</p>\n<p>•&nbsp;JD.com (NASDAQ:JD) is likely to report quarterly earnings at $0.32 per share on revenue of $33.91 billion.</p>\n<p>• Atkore (NYSE:ATKR) is estimated to report quarterly earnings at $3.84 per share on revenue of $839.38 million.</p>\n<p>• Macy's (NYSE:M) is estimated to report quarterly earnings at $0.29 per share on revenue of $5.18 billion.</p>\n<p>• Kohl's (NYSE:KSS) is likely to report quarterly earnings at $0.64 per share on revenue of $4.27 billion.</p>\n<p>• Brady (NYSE:BRC) is likely to report quarterly earnings at $0.75 per share on revenue of $313.79 million.</p>\n<p>• Maximus (NYSE:MMS) is expected to report quarterly earnings at $0.87 per share on revenue of $1.08 billion.</p>\n<p>• Autohome (NYSE:ATHM) is projected to report quarterly earnings at $0.72 per share on revenue of $271.29 million.</p>\n<p>• New Jersey Resources (NYSE:NJR) is likely to report quarterly earnings at $0.08 per share on revenue of $380.50 million.</p>\n<p>• Yatsen Holding (NYSE:YSG) is estimated to report quarterly loss at $0.06 per share on revenue of $213.92 million.</p>\n<p>• Calliditas Therapeutics (NASDAQ:CALT) is estimated to report earnings for its third quarter.</p>\n<p>• FinVolution Gr (NYSE:FINV) is estimated to report earnings for its third quarter.</p>\n<p>• Hoegh LNG Partners (NYSE:HMLP) is likely to report quarterly earnings at $0.35 per share on revenue of $35.38 million.</p>\n<p>• KNOT Offshore Partners (NYSE:KNOP) is estimated to report quarterly earnings at $0.64 per share on revenue of $70.80 million.</p>\n<p>• Petco Health and Wellness (NASDAQ:WOOF) is projected to report earnings for its third quarter.</p>\n<p>• MINISO Group Holding (NYSE:MNSO) is estimated to report quarterly earnings at $0.06 per share on revenue of $394.90 million.</p>\n<p>• ATRenew (NYSE:RERE) is projected to report earnings for its third quarter.</p>\n<p>• Gambling.com Gr (NASDAQ:GAMB) is expected to report quarterly earnings at $0.07 per share on revenue of $10.36 million.</p>\n<p>• Full Truck Alliance Co (NYSE:YMM) is expected to report quarterly loss at $0.01 per share on revenue of $171.52 million.</p>\n<p>• Cloopen Group Holding (NYSE:RAAS) is estimated to report earnings for its third quarter.</p>\n<p>• OneWater Marine (NASDAQ:ONEW) is expected to report quarterly earnings at $1.17 per share on revenue of $292.16 million.</p>\n<p>• AZEK Co (NYSE:AZEK) is projected to report quarterly earnings at $0.28 per share on revenue of $329.14 million.</p>\n<p>• Portillos (NASDAQ:PTLO) is projected to report earnings for its third quarter.</p>\n<p>• Vipshop Holdings (NYSE:VIPS) is projected to report quarterly earnings at $0.25 per share on revenue of $3.89 billion.</p>\n<p>• Berry Global Group (NYSE:BERY) is projected to report quarterly earnings at $1.52 per share on revenue of $3.48 billion.</p>\n<p>Companies Reporting After The Bell</p>\n<p>• Dynagas LNG Partners (NYSE:DLNG) is likely to report earnings for its third quarter.</p>\n<p>• Ault Global Holdings (AMEX:DPW) is projected to report earnings for its third quarter.</p>\n<p>• Caleres (NYSE:CAL) is expected to report quarterly earnings at $1.14 per share on revenue of $753.48 million.</p>\n<p>• ESCO Technologies (NYSE:ESE) is projected to report quarterly earnings at $0.78 per share on revenue of $201.18 million.</p>\n<p>• Globant (NYSE:GLOB) is expected to report quarterly earnings at $0.93 per share on revenue of $326.90 million.</p>\n<p>• Intuit (NASDAQ:INTU) is projected to report quarterly earnings at $0.99 per share on revenue of $1.81 billion.</p>\n<p>• Beacon Roofing Supply (NASDAQ:BECN) is estimated to report quarterly earnings at $1.54 per share on revenue of $1.88 billion.</p>\n<p>• Applied Materials (NASDAQ:AMAT) is projected to report quarterly earnings at $1.95 per share on revenue of $6.34 billion.</p>\n<p>• Palo Alto Networks (NASDAQ:PANW) is expected to report quarterly earnings at $1.57 per share on revenue of $1.20 billion.</p>\n<p>• Post Holdings (NYSE:POST) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.65 billion.</p>\n<p>• American Software (NASDAQ:AMSWA) is estimated to report quarterly earnings at $0.07 per share on revenue of $29.69 million.</p>\n<p>• Williams-Sonoma (NYSE:WSM) is likely to report quarterly earnings at $3.08 per share on revenue of $1.97 billion.</p>\n<p>• Delta Apparel (AMEX:DLA) is expected to report quarterly earnings at $0.56 per share on revenue of $109.40 million.</p>\n<p>• Workday (NASDAQ:WDAY) is expected to report quarterly earnings at $0.86 per share on revenue of $1.31 billion.</p>\n<p>• Nuance Communications (NASDAQ:NUAN) is expected to report quarterly earnings at $0.20 per share on revenue of $352.90 million.</p>\n<p>• Ross Stores (NASDAQ:ROST) is estimated to report quarterly earnings at $0.78 per share on revenue of $4.33 billion.</p>\n<p>• UGI (NYSE:UGI) is likely to report quarterly loss at $0.26 per share on revenue of $1.26 billion.</p>\n<p>• VNET Group (NASDAQ:VNET) is estimated to report quarterly loss at $0.06 per share on revenue of $241.16 million.</p>\n<p>• Woodward (NASDAQ:WWD) is expected to report quarterly earnings at $0.86 per share on revenue of $605.22 million.</p>\n<p>• BellRing Brands (NYSE:BRBR) is projected to report quarterly earnings at $0.25 per share on revenue of $350.45 million.</p>\n<p>• Farfetch (NYSE:FTCH) is estimated to report quarterly loss at $0.36 per share on revenue of $591.34 million.</p>\n<p>• Haynes Intl (NASDAQ:HAYN) is likely to report quarterly earnings at $0.07 per share on revenue of $93.02 million.</p>\n<p>• OneConnect Financial Tech (NYSE:OCFT) is estimated to report quarterly loss at $0.12 per share on revenue of $165.14 million.</p>\n<p>• Matthews International (NASDAQ:MATW) is expected to report quarterly earnings at $0.75 per share on revenue of $393.53 million.</p>\n<p>• Natural Grocers (NYSE:NGVC) is estimated to report earnings for its fourth quarter.</p>\n<p>• Geospace Technologies (NASDAQ:GEOS) is projected to report earnings for its fourth quarter.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Earnings Scheduled For November 18, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEarnings Scheduled For November 18, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 18:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/earnings/21/11/24163535/earnings-scheduled-for-november-18-2021><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Companies Reporting Before The Bell\n• Alibaba Group Holding (NYSE:BABA) is expected to report quarterly earnings at $1.93 per share on revenue of $32.05 billion.\n• Mechel PAO (NYSE:MTL) is estimated ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/11/24163535/earnings-scheduled-for-november-18-2021\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JD":"京东","BABA":"阿里巴巴"},"source_url":"https://www.benzinga.com/news/earnings/21/11/24163535/earnings-scheduled-for-november-18-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184486139","content_text":"Companies Reporting Before The Bell\n• Alibaba Group Holding (NYSE:BABA) is expected to report quarterly earnings at $1.93 per share on revenue of $32.05 billion.\n• Mechel PAO (NYSE:MTL) is estimated to report earnings for its third quarter.\n• BioLine Rx (NASDAQ:BLRX) is projected to report earnings for its third quarter.\n• Children's Place (NASDAQ:PLCE) is projected to report earnings for its third quarter.\n• BIT Mining (NYSE:BTCM) is expected to report earnings for its third quarter.\n• Canadian Solar (NASDAQ:CSIQ) is estimated to report quarterly earnings at $0.18 per share on revenue of $1.33 billion.\n• BJ's Wholesale Club (NYSE:BJ) is projected to report quarterly earnings at $0.78 per share on revenue of $3.85 billion.\n• JD.com (NASDAQ:JD) is likely to report quarterly earnings at $0.32 per share on revenue of $33.91 billion.\n• Atkore (NYSE:ATKR) is estimated to report quarterly earnings at $3.84 per share on revenue of $839.38 million.\n• Macy's (NYSE:M) is estimated to report quarterly earnings at $0.29 per share on revenue of $5.18 billion.\n• Kohl's (NYSE:KSS) is likely to report quarterly earnings at $0.64 per share on revenue of $4.27 billion.\n• Brady (NYSE:BRC) is likely to report quarterly earnings at $0.75 per share on revenue of $313.79 million.\n• Maximus (NYSE:MMS) is expected to report quarterly earnings at $0.87 per share on revenue of $1.08 billion.\n• Autohome (NYSE:ATHM) is projected to report quarterly earnings at $0.72 per share on revenue of $271.29 million.\n• New Jersey Resources (NYSE:NJR) is likely to report quarterly earnings at $0.08 per share on revenue of $380.50 million.\n• Yatsen Holding (NYSE:YSG) is estimated to report quarterly loss at $0.06 per share on revenue of $213.92 million.\n• Calliditas Therapeutics (NASDAQ:CALT) is estimated to report earnings for its third quarter.\n• FinVolution Gr (NYSE:FINV) is estimated to report earnings for its third quarter.\n• Hoegh LNG Partners (NYSE:HMLP) is likely to report quarterly earnings at $0.35 per share on revenue of $35.38 million.\n• KNOT Offshore Partners (NYSE:KNOP) is estimated to report quarterly earnings at $0.64 per share on revenue of $70.80 million.\n• Petco Health and Wellness (NASDAQ:WOOF) is projected to report earnings for its third quarter.\n• MINISO Group Holding (NYSE:MNSO) is estimated to report quarterly earnings at $0.06 per share on revenue of $394.90 million.\n• ATRenew (NYSE:RERE) is projected to report earnings for its third quarter.\n• Gambling.com Gr (NASDAQ:GAMB) is expected to report quarterly earnings at $0.07 per share on revenue of $10.36 million.\n• Full Truck Alliance Co (NYSE:YMM) is expected to report quarterly loss at $0.01 per share on revenue of $171.52 million.\n• Cloopen Group Holding (NYSE:RAAS) is estimated to report earnings for its third quarter.\n• OneWater Marine (NASDAQ:ONEW) is expected to report quarterly earnings at $1.17 per share on revenue of $292.16 million.\n• AZEK Co (NYSE:AZEK) is projected to report quarterly earnings at $0.28 per share on revenue of $329.14 million.\n• Portillos (NASDAQ:PTLO) is projected to report earnings for its third quarter.\n• Vipshop Holdings (NYSE:VIPS) is projected to report quarterly earnings at $0.25 per share on revenue of $3.89 billion.\n• Berry Global Group (NYSE:BERY) is projected to report quarterly earnings at $1.52 per share on revenue of $3.48 billion.\nCompanies Reporting After The Bell\n• Dynagas LNG Partners (NYSE:DLNG) is likely to report earnings for its third quarter.\n• Ault Global Holdings (AMEX:DPW) is projected to report earnings for its third quarter.\n• Caleres (NYSE:CAL) is expected to report quarterly earnings at $1.14 per share on revenue of $753.48 million.\n• ESCO Technologies (NYSE:ESE) is projected to report quarterly earnings at $0.78 per share on revenue of $201.18 million.\n• Globant (NYSE:GLOB) is expected to report quarterly earnings at $0.93 per share on revenue of $326.90 million.\n• Intuit (NASDAQ:INTU) is projected to report quarterly earnings at $0.99 per share on revenue of $1.81 billion.\n• Beacon Roofing Supply (NASDAQ:BECN) is estimated to report quarterly earnings at $1.54 per share on revenue of $1.88 billion.\n• Applied Materials (NASDAQ:AMAT) is projected to report quarterly earnings at $1.95 per share on revenue of $6.34 billion.\n• Palo Alto Networks (NASDAQ:PANW) is expected to report quarterly earnings at $1.57 per share on revenue of $1.20 billion.\n• Post Holdings (NYSE:POST) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.65 billion.\n• American Software (NASDAQ:AMSWA) is estimated to report quarterly earnings at $0.07 per share on revenue of $29.69 million.\n• Williams-Sonoma (NYSE:WSM) is likely to report quarterly earnings at $3.08 per share on revenue of $1.97 billion.\n• Delta Apparel (AMEX:DLA) is expected to report quarterly earnings at $0.56 per share on revenue of $109.40 million.\n• Workday (NASDAQ:WDAY) is expected to report quarterly earnings at $0.86 per share on revenue of $1.31 billion.\n• Nuance Communications (NASDAQ:NUAN) is expected to report quarterly earnings at $0.20 per share on revenue of $352.90 million.\n• Ross Stores (NASDAQ:ROST) is estimated to report quarterly earnings at $0.78 per share on revenue of $4.33 billion.\n• UGI (NYSE:UGI) is likely to report quarterly loss at $0.26 per share on revenue of $1.26 billion.\n• VNET Group (NASDAQ:VNET) is estimated to report quarterly loss at $0.06 per share on revenue of $241.16 million.\n• Woodward (NASDAQ:WWD) is expected to report quarterly earnings at $0.86 per share on revenue of $605.22 million.\n• BellRing Brands (NYSE:BRBR) is projected to report quarterly earnings at $0.25 per share on revenue of $350.45 million.\n• Farfetch (NYSE:FTCH) is estimated to report quarterly loss at $0.36 per share on revenue of $591.34 million.\n• Haynes Intl (NASDAQ:HAYN) is likely to report quarterly earnings at $0.07 per share on revenue of $93.02 million.\n• OneConnect Financial Tech (NYSE:OCFT) is estimated to report quarterly loss at $0.12 per share on revenue of $165.14 million.\n• Matthews International (NASDAQ:MATW) is expected to report quarterly earnings at $0.75 per share on revenue of $393.53 million.\n• Natural Grocers (NYSE:NGVC) is estimated to report earnings for its fourth quarter.\n• Geospace Technologies (NASDAQ:GEOS) is projected to report earnings for its fourth quarter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691727515,"gmtCreate":1640248798723,"gmtModify":1640248798854,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691727515","repostId":"1138529637","repostType":4,"repost":{"id":"1138529637","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640245035,"share":"https://www.laohu8.com/m/news/1138529637?lang=&edition=full","pubTime":"2021-12-23 15:37","market":"us","language":"en","title":"AstraZeneca vaccine booster shot effective against Omicron -Oxford lab study","url":"https://stock-news.laohu8.com/highlight/detail?id=1138529637","media":"Reuters","summary":"Dec 23 (Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Om","content":"<p>Dec 23 (Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.</p>\n<p>The study, yet to be published in a peer-reviewed medical journal, showed&nbsp;antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.</p>\n<p>After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus's Delta variant after two doses, the company added.</p>\n<p>The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca vaccine booster shot effective against Omicron -Oxford lab study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca vaccine booster shot effective against Omicron -Oxford lab study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 15:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 23 (Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.</p>\n<p>The study, yet to be published in a peer-reviewed medical journal, showed&nbsp;antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.</p>\n<p>After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus's Delta variant after two doses, the company added.</p>\n<p>The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138529637","content_text":"Dec 23 (Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.\nThe study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.\nAfter a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus's Delta variant after two doses, the company added.\nThe Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca.","news_type":1},"isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691169180,"gmtCreate":1640150438778,"gmtModify":1640150438917,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691169180","repostId":"1157657338","repostType":4,"repost":{"id":"1157657338","pubTimestamp":1640144039,"share":"https://www.laohu8.com/m/news/1157657338?lang=&edition=full","pubTime":"2021-12-22 11:33","market":"us","language":"en","title":"3 Stocks to Buy in a Heartbeat If There's a Stock Market Crash in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1157657338","media":"Motley Fool","summary":"Each has an excellent future, and a stock market crash could give investors a chance to buy them at lower prices.","content":"<p><b>Key Points</b></p>\n<ul>\n <li>Airbnb is arguably a better business now than before the pandemic.</li>\n <li>Apple's iPhone is capturing new customers for its ecosystem.</li>\n <li>Amazon's more profitable segments are growing faster.</li>\n</ul>\n<p>Stock market crashes are nearly impossible to predict with any precision. However, investors can prepare for a crash by setting aside extra cash in their portfolios in anticipation. That way, if there is a market crash, investors have cash on hand and are ready to deploy it in buying excellent stocks at lower prices.</p>\n<p>In that regard, if there is a stock market crash in 2022,<b>Airbnb</b>(NASDAQ:ABNB),<b>Apple</b>(NASDAQ:AAPL), and&nbsp;<b>Amazon</b>(NASDAQ:AMZN)&nbsp;are three stocks you can buy in a heartbeat. Let's look closer at the case for why each stock deserves a spot in your portfolio.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3131619f7941ecc473ad8787d0fa380d\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>Airbnb</b></p>\n<p>The worldwide facilitator of travel, Airbnb is steadily recovering from the devastation caused by the&nbsp;coronavirus pandemic. After two years of growth, Airbnb's revenue decreased 30% to $3.4 billion in 2020.</p>\n<p>Thankfully, several effective vaccines have been developed against COVID-19, and that's made folks more willing to travel again in 2021. So sales are bouncing back at Airbnb. In its most recent fiscal quarter ended Sept. 30, revenue was up 36% over the comparable pre-pandemic quarter in 2019. Even more impressively, net income increased to $834 million in the third quarter, up from $267 million in Q3 of 2019.</p>\n<p>The company is gaining traction&nbsp;in the lucrative travel and resort industry that could be worth over $1 trillion in sales annually. Folks can often find places to stay on Airbnb's platform that are better fitted to their needs compared to hotels, which are less customizable.</p>\n<p>Airbnb's stock is trading at a price-to-free-cash-flow ratio of 59 -- its lowest all year -- and a stock market crash could cause it to sell at an even lower price.</p>\n<p><b>Apple</b></p>\n<p>Unlike Airbnb, Apple's business has been thriving since the pandemic's onset. The company's products are more valuable to people working, learning, and entertaining themselves at home.</p>\n<p>But that's not the only factor driving sales higher for Apple. The tech giant has done a masterful job updating legacy products like the iPhone in a fashion that keeps consumers interested. The most recent iPhone update has increased sales of the product to $192 billion in its latest fiscal year ended Sept. 25, up from $138 billion a year ago.</p>\n<p>Apple has proven this capability for years. In the past decade alone, its revenue has grown at a compound annual rate of 12.9%. That's a difficult feat for a company the size of Apple with sales of $366 billion in its fiscal 2021.</p>\n<p>What's more, sales of its products are bringing customers into its ecosystem -- and once with Apple, consumers tend to stick around. Indeed, sales from its services segment totaled $54 billion in 2021, and those sales produce a higher profit margin than its products do.</p>\n<p>One of the only downsides to Apple's stock is its price. The company is&nbsp;approaching a $3 trillion market cap&nbsp;and is trading at a price-to-free-cash-flow ratio of 31 -- near the highs of the past decade. A stock market crash could alleviate some valuation concerns and allow you to buy Apple stock at a lower price.</p>\n<p><b>Amazon</b></p>\n<p>Sales at Amazon, the titan of online retailers, have been surging throughout the pandemic. The company stepped up and delivered while hundreds of millions of folks were looking to avoid shopping in person for fear of contracting COVID-19. Indeed, from fiscal 2019 to 2020, Amazon's sales rose by more than $100 billion. The 37.6% increase in year-over-year sales drove operating profits from $14.5 billion to $22.9 billion. Amazon has gained millions of customers during the pandemic, and undoubtedly many of them will stick around long after.</p>\n<p>Interestingly, Amazon's more profitable segments are growing faster than the company overall. In the most recent quarter ended Sept. 30, revenue from its Amazon Web Services segment (which provides cloud computing to businesses) rose 39% year over year to $16.1 billion while the category that includes advertising revenue jumped 49% to $8.1 billion. In fact, since Q2 2020, the ad revenue category has nearly doubled.</p>\n<p>Amazon is riding multiple tailwinds, including increased shopping online as well as greater&nbsp;advertising online. These trends could propel sales growth for several more years. Amazon's stock is not cheap, trading at a price-to-free-cash flow ratio of 239 and a price-to-earnings ratio of 66, but a stock market crash could give investors a chance to buy it at a lower price.</p>\n<p>Airbnb, Apple, and Amazon are all excellent businesses with solid prospects over several years. If there's a stock market crash in 2022 that sends these&nbsp;stocks&nbsp;lower, investors should jump at the opportunity to buy them.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Buy in a Heartbeat If There's a Stock Market Crash in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Buy in a Heartbeat If There's a Stock Market Crash in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 11:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/21/3-stocks-to-buy-in-stockmarket-crash-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nAirbnb is arguably a better business now than before the pandemic.\nApple's iPhone is capturing new customers for its ecosystem.\nAmazon's more profitable segments are growing faster.\n\nStock...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/21/3-stocks-to-buy-in-stockmarket-crash-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABNB":"爱彼迎","AMZN":"亚马逊","AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2021/12/21/3-stocks-to-buy-in-stockmarket-crash-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157657338","content_text":"Key Points\n\nAirbnb is arguably a better business now than before the pandemic.\nApple's iPhone is capturing new customers for its ecosystem.\nAmazon's more profitable segments are growing faster.\n\nStock market crashes are nearly impossible to predict with any precision. However, investors can prepare for a crash by setting aside extra cash in their portfolios in anticipation. That way, if there is a market crash, investors have cash on hand and are ready to deploy it in buying excellent stocks at lower prices.\nIn that regard, if there is a stock market crash in 2022,Airbnb(NASDAQ:ABNB),Apple(NASDAQ:AAPL), and Amazon(NASDAQ:AMZN) are three stocks you can buy in a heartbeat. Let's look closer at the case for why each stock deserves a spot in your portfolio.\nIMAGE SOURCE: GETTY IMAGES.\nAirbnb\nThe worldwide facilitator of travel, Airbnb is steadily recovering from the devastation caused by the coronavirus pandemic. After two years of growth, Airbnb's revenue decreased 30% to $3.4 billion in 2020.\nThankfully, several effective vaccines have been developed against COVID-19, and that's made folks more willing to travel again in 2021. So sales are bouncing back at Airbnb. In its most recent fiscal quarter ended Sept. 30, revenue was up 36% over the comparable pre-pandemic quarter in 2019. Even more impressively, net income increased to $834 million in the third quarter, up from $267 million in Q3 of 2019.\nThe company is gaining traction in the lucrative travel and resort industry that could be worth over $1 trillion in sales annually. Folks can often find places to stay on Airbnb's platform that are better fitted to their needs compared to hotels, which are less customizable.\nAirbnb's stock is trading at a price-to-free-cash-flow ratio of 59 -- its lowest all year -- and a stock market crash could cause it to sell at an even lower price.\nApple\nUnlike Airbnb, Apple's business has been thriving since the pandemic's onset. The company's products are more valuable to people working, learning, and entertaining themselves at home.\nBut that's not the only factor driving sales higher for Apple. The tech giant has done a masterful job updating legacy products like the iPhone in a fashion that keeps consumers interested. The most recent iPhone update has increased sales of the product to $192 billion in its latest fiscal year ended Sept. 25, up from $138 billion a year ago.\nApple has proven this capability for years. In the past decade alone, its revenue has grown at a compound annual rate of 12.9%. That's a difficult feat for a company the size of Apple with sales of $366 billion in its fiscal 2021.\nWhat's more, sales of its products are bringing customers into its ecosystem -- and once with Apple, consumers tend to stick around. Indeed, sales from its services segment totaled $54 billion in 2021, and those sales produce a higher profit margin than its products do.\nOne of the only downsides to Apple's stock is its price. The company is approaching a $3 trillion market cap and is trading at a price-to-free-cash-flow ratio of 31 -- near the highs of the past decade. A stock market crash could alleviate some valuation concerns and allow you to buy Apple stock at a lower price.\nAmazon\nSales at Amazon, the titan of online retailers, have been surging throughout the pandemic. The company stepped up and delivered while hundreds of millions of folks were looking to avoid shopping in person for fear of contracting COVID-19. Indeed, from fiscal 2019 to 2020, Amazon's sales rose by more than $100 billion. The 37.6% increase in year-over-year sales drove operating profits from $14.5 billion to $22.9 billion. Amazon has gained millions of customers during the pandemic, and undoubtedly many of them will stick around long after.\nInterestingly, Amazon's more profitable segments are growing faster than the company overall. In the most recent quarter ended Sept. 30, revenue from its Amazon Web Services segment (which provides cloud computing to businesses) rose 39% year over year to $16.1 billion while the category that includes advertising revenue jumped 49% to $8.1 billion. In fact, since Q2 2020, the ad revenue category has nearly doubled.\nAmazon is riding multiple tailwinds, including increased shopping online as well as greater advertising online. These trends could propel sales growth for several more years. Amazon's stock is not cheap, trading at a price-to-free-cash flow ratio of 239 and a price-to-earnings ratio of 66, but a stock market crash could give investors a chance to buy it at a lower price.\nAirbnb, Apple, and Amazon are all excellent businesses with solid prospects over several years. If there's a stock market crash in 2022 that sends these stocks lower, investors should jump at the opportunity to buy them.","news_type":1},"isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607592611,"gmtCreate":1639558048783,"gmtModify":1639558048926,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607592611","repostId":"1107549050","repostType":4,"repost":{"id":"1107549050","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639552499,"share":"https://www.laohu8.com/m/news/1107549050?lang=&edition=full","pubTime":"2021-12-15 15:14","market":"us","language":"en","title":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=1107549050","media":"Tiger Newspress","summary":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and c","content":"<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p>\n<ul>\n <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>\n <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>\n <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li>\n</ul>\n<p>Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p>\n<p>The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p>\n<p>Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p>\n<p><i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p>\n<p>Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p>\n<p>In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p>\n<p><b>About the booster trial (VAT0002)</b></p>\n<p>The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p>\n<p>Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p>\n<p>The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p>\n<p><b>About the Phase 3 efficacy trial (VAT0008)</b></p>\n<p>The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p>\n<p>These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p>\n<p><b>About the Sanofi and GSK collaboration</b></p>\n<p>In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p>\n<p><b>About GSK</b></p>\n<p>GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p>\n<p><b>About Sanofi</b></p>\n<p>Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p>\n<p>With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-15 15:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p>\n<ul>\n <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>\n <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>\n <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li>\n</ul>\n<p>Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p>\n<p>The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p>\n<p>Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p>\n<p><i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p>\n<p>Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p>\n<p>In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p>\n<p><b>About the booster trial (VAT0002)</b></p>\n<p>The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p>\n<p>Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p>\n<p>The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p>\n<p><b>About the Phase 3 efficacy trial (VAT0008)</b></p>\n<p>The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p>\n<p>These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p>\n<p><b>About the Sanofi and GSK collaboration</b></p>\n<p>In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p>\n<p><b>About GSK</b></p>\n<p>GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p>\n<p><b>About Sanofi</b></p>\n<p>Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p>\n<p>With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNY":"赛诺菲安万特","GSK":"葛兰素史克"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107549050","content_text":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation\n\nPositive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile\nPhase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022\nCompanies intend to file booster data with regulatory authorities following the Phase 3 results\n\nSanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson & Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.\nThe ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.\nRegulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.\n“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”\nRoger Connor, President of GSK Vaccines, added: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"\nIn parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson & Johnson vaccines.\nAbout the booster trial (VAT0002)\nThe VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.\nParticipants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson & Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.\nThe trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.\nAbout the Phase 3 efficacy trial (VAT0008)\nThe primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants >18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.\nThese efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.\nAbout the Sanofi and GSK collaboration\nIn the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.\nAbout GSK\nGSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.\nAbout Sanofi\nSanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.\nWith more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.","news_type":1},"isVote":1,"tweetType":1,"viewCount":517,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607594306,"gmtCreate":1639558189048,"gmtModify":1639558189137,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607594306","repostId":"1196328402","repostType":4,"isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879448323,"gmtCreate":1636767722663,"gmtModify":1636767722708,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879448323","repostId":"1116750872","repostType":4,"isVote":1,"tweetType":1,"viewCount":289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847265676,"gmtCreate":1636525440667,"gmtModify":1636525494706,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"suspend","listText":"suspend","text":"suspend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847265676","repostId":"1102766884","repostType":4,"isVote":1,"tweetType":1,"viewCount":233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603225178,"gmtCreate":1638415865790,"gmtModify":1638416122805,"author":{"id":"4087725712090890","authorId":"4087725712090890","name":"thaigirl","avatar":"https://static.tigerbbs.com/1cd5b53436744d0d0b70ba07437b7af1","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"ah","listText":"ah","text":"ah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603225178","repostId":"1197247033","repostType":2,"isVote":1,"tweetType":1,"viewCount":496,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}